Document:

Allora Minerals, Inc.: Exhibit 4.2 - Prepared by TNT Filings Inc.

Exhibit 4.2 

THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“SECURITIES ACT”), OR ANY STATE SECURITIES LAW, AND MAY NOT BE SOLD,
TRANSFERRED, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF OR
EXERCISED UNLESS (i) A REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND
APPLICABLE STATE SECURITIES LAWS SHALL HAVE BECOME EFFECTIVE WITH REGARD
THERETO, OR (ii) AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT AND
APPLICABLE STATE SECURITIES LAWS IS AVAILABLE IN CONNECTION WITH SUCH OFFER,
SALE OR TRANSFER. 

AN INVESTMENT IN THESE SECURITIES INVOLVES A HIGH DEGREE OF
RISK. HOLDERS MUST RELY ON THEIR OWN ANALYSIS OF THE INVESTMENT AND ASSESSMENT
OF THE RISKS INVOLVED.

	Warrant to Purchase 	  
	172,414 shares 	Warrant Number 1 

Warrant to Purchase Common Stock 
of 
EPOD Solar, Inc.

          THIS
CERTIFIES that Dr. Chandra Pemmasani, with an address at 8 Fieldstream Court,
Lutherville, MD 21093, or any subsequent holder hereof (“Holder”) has the
right to purchase from EPOD Solar Inc., a corporation formed pursuant to
the laws of the province of British Columbia, Canada with a principal office at
5 – 215 Neave Road, Kelowna, British Columbia, Canada V1V 2L9 (the
“Company”), up to One Hundred Seventy-Two Thousand Four Hundred Fourteen
(172,414) fully paid and nonassessable shares of (a) the Company's common stock,
no par value per share (“EPOD Stock”), or (b) common stock, $0.001 par
value per share (“Allora Stock”) of Allora Minerals, Inc., a Nevada
corporation with a principal office at 5 – 215 Neave Road, Kelowna, British
Columbia, Canada V1V 2L9 (“Allora”), in accordance with the terms and
conditions hereof and subject to adjustment as provided herein, at a price equal
to the Exercise Price as defined in Section 3 below, at any time during the Term
(as defined below).

          Holder
agrees with the Company that this Warrant to Purchase Common Stock of the
Company (this “Warrant” or this “Agreement”) is issued and all
rights hereunder shall be held subject to all of the conditions, limitations and
provisions set forth herein. 

         
1.      Date of Issuance; Term; Beneficial Ownership
Limitation. 

          This
Warrant shall be deemed to be issued on June 30, 2009 (“Date of
Issuance”). The term of this Warrant begins on the Date of Issuance and ends
at 5:00 p.m., New York City time, on the date that is five (5) years after the
Date of Issuance (the “Term”). This Warrant was issued in conjunction
with the issuance of Debentures of the Company (the “Debentures”)
to the Holder pursuant to the terms of that certain Securities Purchase
Agreement, by and among the Company, Allora and Holder, dated on or about June
30, 2009 (the “Purchase Agreement”), and the Registration
Rights Agreement, by and between Allora and Holder dated on or about June 30,
2009 (“Registration Rights Agreement”). Capitalized terms used but not
defined herein shall have the meanings ascribed to them in the Purchase
Agreement or the Debentures, as applicable.

1 

          When
and/or to the extent that this Warrant is exercisable by the Holder for shares
of Allora Stock, and notwithstanding anything to the contrary herein, the
applicable portion of this Warrant shall not be exercisable during any time
that, and only to the extent that, the number of shares of Allora Stock, as and
to the extent applicable, to be issued to Holder upon such Exercise (as defined
in Section 2(a)), when added to the number of shares of Common Stock, if any,
that the Holder otherwise beneficially owns (outside of this Warrant, and not
including any other warrants or securities of Holder’s having a provision
substantially similar to this paragraph) at the time of such Exercise, would
exceed 4.99% (the “Maximum Percentage”) of the number of shares of Allora
Stock outstanding immediately after giving effect to the issuance of shares of
Allora Stock issuable upon Exercise of this Warrant held by the Holder, as
determined in accordance with Section 13(d) of the Securities Exchange Act of
1934, as amended, and the rules and regulations promulgated thereunder (the
“Beneficial Ownership Limitation”). The Beneficial Ownership Limitation
shall be conclusively satisfied if the applicable Notice of Exercise includes a
signed representation by the Holder that the issuance of the shares of Allora
Stock in such Notice of Exercise will not violate the Beneficial Ownership
Limitation, and Allora shall not be entitled to require additional documentation
of such satisfaction. 

          Notwithstanding
the above, at such time, and to the extent, that this Warrant is exercisable by
the Holder for shares of Allora Stock, and in the event that Allora receives any
purchase, tender or exchange offer or any offer to enter into a merger with
another entity whereby the Company shall not be the surviving entity (an
“Offer”), then the Maximum Percentage shall be increased (but not
decreased) to 9.99%, and “4.99%” shall be automatically revised immediately
after such offer to read “9.99%” each place it occurs in this Section 1. The
Beneficial Ownership Limitation provisions of this Section 1 may be waived by
such Holder, at the election of such Holder, upon not less than 61 days’ prior
notice to Allora, to change the Beneficial Ownership Limitation to any amount
not in excess of 9.99% of the number of shares of Allora Stock outstanding
immediately after giving effect to the issuance of shares of Allora Stock upon
Exercise of this Warrant held by the Holder and the Beneficial Ownership
Limitation shall continue to apply. Upon such a change by a Holder of the
Beneficial Ownership Limitation from such 4.99% limitation to such 9.99%
limitation, the Beneficial Ownership Limitation may not be further waived by
such Holder; provided that, if an Event of Default occurs, thereafter the
Beneficial Ownership Limitation provisions of this Section 1 may be waived by
such Holder, at the election of such Holder, upon not less than 61 days’ prior
notice to the Company, to change the Maximum Percentage to any other percentage
(and not limited to 9.99%) of the number of shares of the Common Stock
outstanding immediately after giving effect to the issuance of shares of Allora
Stock upon Exercise of the Warrants held by the Holder and the provisions of
this Section 1 shall continue to apply. The limitations on Exercise set forth in
this subsection are referred to as the “Beneficial Ownership
Limitations”. The provisions of this paragraph shall be construed and
implemented in a manner otherwise than in strict conformity with the terms of
this Section 1 to correct this Section (or any portion hereof) which may be
defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or
desirable to properly give effect to such limitation.

2

          Notwithstanding
the above, Holder shall retain the option to either Exercise or not Exercise
this Warrant pursuant to the terms hereof after an Offer, and, in the event of a
cash Exercise following a tender offer, the Exercise Price per share that would
otherwise be due shall instead be offset against the tender price per share to
be received by the Holder; provided, however, that in the event a tender offer
is not completed, Holder, at its option may either (i) complete any Exercise
that was initiated after the Offer by promptly paying to Allora the Exercise
Price that would have been due at the time the Warrant was Exercised, or (ii)
cancel such Exercise by providing written notice to Allora, in which case such
Exercise shall be deemed void ad initio. 

          In
the event the Holder notifies Allora that the Exercise of the rights described
herein would result in the issuance of an amount of Allora Stock of the Company
that would exceed the maximum amount that may be issued to a Holder calculated
in the manner described above, then the issuance of such additional shares of
Allora Stock to such Holder will be deferred in whole or in part until such time
as such Holder is able to beneficially own such Allora Stock without exceeding
the maximum amount calculated in the manner described herein. The determination
of when such Allora Stock may be issued shall be made by each Holder as to only
such Holder.

          2.     
Exercise. 

          (a)
Manner of Exercise. During the Term, this Warrant may be Exercised as to all
or any lesser number of full shares of EPOD Stock or Allora Stock, as
applicable, covered hereby (the “Exercise Shares” or the “Shares”)
and in the manner set forth below, upon surrender of this Warrant, with the
Notice of Exercise Form attached hereto as Exhibit A (the “Notice of
Exercise”) duly completed and executed, together with the full Exercise
Price (as defined below, which may be satisfied by either a Cash Exercise or a
Cashless Exercise, as each is defined below) for each share of EPOD Stock or
Allora Stock, as applicable, as to which this Warrant is Exercised, at the
office of the Company or Allora, as applicable, or at such other location as the
Company or Allora, as applicable, may then be located or such other office or
agency as the Company or Allora, as applicable, may designate in writing, by
overnight mail, by facsimile (such surrender and payment of the Exercise Price
hereinafter called the “Exercise” of this Warrant). In the case of a
Cashless Exercise, the Exercise Price is deemed to have been delivered upon the
Holder’s delivery of a Notice of Exercise to the Company or Allora, as
applicable. 

          This
Warrant may be Exercised by the Holder during the Term as follows: 

                    (i)      At
the election of the Holder, for a period beginning on the Date of Issuance and
ending on the date of closing of the Asset Purchase (as defined in the Purchase
Agreement), into shares of EPOD Stock or Allora Stock.

                    (ii)     
In the event that (A) this Warrant was issued to the Holder in a subsequent
Closing pursuant to Section 1.07 of the Purchase Agreement, or (B) this Warrant is being Exercised by the Holder after the closing of
the Asset Purchase, this Warrant shall be solely exercisable for shares of
Allora Stock. 

3

                    (iii)      In
the event that the closing of the Asset Purchase does not take place for any
reason, this Warrant shall be exercisable solely for shares of EPOD Stock. 

          (b)
Date of Exercise. The “Date of Exercise” of this Warrant shall be
defined as the date that a copy of the Notice of Exercise Form attached hereto
as Exhibit A, completed and executed, is sent by facsimile or otherwise
to the Company or Allora, as applicable, or (with respect to Allora) its
transfer agent (“Transfer Agent”) (including but not limited to a scanned
“PDF” file which is delivered as an attachment to an e-mail to the Company);
provided that the original Warrant (if delivery of the original Warrant is
required pursuant to Section 2(l) hereof) and Notice of Exercise Form are
received by the Company or Allora, as applicable, and the Exercise Price is
satisfied, each as soon as practicable thereafter. Alternatively, the Date of
Exercise shall be defined as the date the original Notice of Exercise Form is
received by the Company or Allora, as applicable, if Holder has not sent advance
notice by facsimile. Upon delivery of the Notice of Exercise Form to the Company
or Allora, as applicable, by facsimile or otherwise, the Holder shall be deemed
for all corporate purposes to have become the holder of record of the Exercise
Shares with respect to which this Warrant has been Exercised pursuant to Section
2(a)(i) and (ii), irrespective of the date such Exercise Shares are credited to
the Holder’s DTC account or the date of delivery of the certificates evidencing
such Exercise Shares as the case may be. The Company or Allora, as applicable,
shall deliver any objection to any Notice of Exercise within 1 Business Day of
receipt of such notice. In the event of any dispute or discrepancy, the records
of the Holder shall be controlling and determinative in the absence of manifest
error. 

          (c)
Delivery of Exercise Shares Upon Exercise. Within five (5) Business Days (as
defined in the Debentures) from the delivery to the Company or Allora, as
applicable, of the Notice of Exercise, surrender of this Warrant (if required)
and payment of the aggregate Exercise Price to the appropriate entity (which, in
the case of a Cashless Exercise, shall be deemed to have been paid upon the
submission by the Holder of a Notice of Exercise) (the “Exercise Shares
Delivery Deadline”), the Company or Allora, as applicable, shall issue and
deliver (or cause the Transfer Agent so to issue and deliver) in accordance with
the terms hereof to or upon the order of the Holder that number of EPOD Exercise
Shares or Allora Exercise Shares (as defined in Section 2(g)(ii), below), as
applicable, for the portion of this Warrant so Exercised as shall be determined
in accordance herewith. Upon the Exercise of this Warrant or any part thereof,
the Company or Allora, as applicable, shall, at its own cost and expense, take
all necessary action, including obtaining and delivering, an opinion of counsel
to assure that the Company or Allora, as applicable, or the Transfer Agent shall
issue stock certificates in the name of Holder (or its nominee) or such other
persons as designated by Holder and in such denominations to be specified at
Exercise representing the number of shares of EPOD Stock or Allora Stock
issuable upon such Exercise. The Company or Allora, as applicable, warrants that
no instructions other than these instructions have been or will be given to the
Company or to the Transfer Agent of the Allora Stock and that, unless waived by
the Holder, the Exercise Shares will be free-trading, and freely transferable,
and will not contain a legend restricting the resale or transferability of the
Exercise Shares if the Unrestricted Conditions (as defined below) are met. If the
Company or Allora, as applicable, fails for any reason to deliver to the Holder
certificates evidencing the Exercise Shares subject to a Notice of Exercise by
the Exercise Shares Delivery Deadline (a “Exercise Shares Delivery
Failure”), the Company or Allora, as applicable, shall pay to the Holder, in
cash, as liquidated damages and not as a penalty, for each $1,000 of Exercise
Shares subject to such Exercise (based on the VWAP (as defined below) of the
Common Stock on the date of the applicable Notice of Exercise), $10 per Business
Day (increasing to $20 per Business Day on the sixth (6th) Business
Day after such liquidated damages begin to accrue) for each Business Day after
such Exercise Shares Delivery Deadline until such certificates are delivered or
the Holder rescinds such Exercise (“Exercise Shares Delivery Failure
Payments”).  

4

          (d)
Payment of Accrued Exercise Shares Delivery Failure Payments. The Company or
Allora, as applicable, shall pay any payments incurred under this Section in
cash or cash equivalent upon demand or, if not demanded sooner, on or before the
fifth (5th) day of each month following a month in which they accrue.
Exercise Shares Delivery Failure Payments are in addition to any Exercise Shares
that the Holder is entitled to receive upon Exercise of this Warrant. Nothing
herein shall limit the Holder’s right to pursue actual damages (to the extent in
excess of the Exercise Shares Delivery Failure Payments) for the Company’s or
Allora’s, as applicable, Exercise Shares Delivery Failure, and the Holder shall
have the right to pursue all remedies available at law or in equity (including a
decree of specific performance and/or injunctive relief).

          (e)
Maximum Interest Rate. Nothing contained herein or in any document referred
to herein or delivered in connection herewith shall be deemed to establish or
require the payment of a rate of interest or other charges in excess of the
maximum permitted by applicable law. In the event that the rate of interest or
dividends required to be paid or other charges hereunder exceed the maximum
permitted by such law, any payments in excess of such maximum shall be credited
against amounts owed by the Company or Allora, as applicable, to the Holder and
thus refunded to the Company or Allora, as applicable. 

          (f)
Revocation of Exercise Upon Delivery Failure. In addition to any
other remedies which may be available to the Holder, in the event that the
Company or Allora, as applicable, fails for any reason to effect delivery of the
Exercise Shares by the Exercise Shares Delivery Deadline, the Holder will be
entitled to revoke all or part of the relevant Notice of Exercise by delivery of
a notice to such effect to the Company or Allora, as applicable, whereupon the
Company or Allora, as applicable, and the Holder shall each be restored to their
respective positions immediately prior to the delivery of such notice, except
that the liquidated damages described above shall be payable through the date
notice of revocation or rescission is given to the Company or Allora, as
applicable. 

          (g)
Legends.

                    (i)
Restrictive Legend. The Holder understands that the Warrant and, until
such time as the shares of Allora Stock issuable upon Exercise hereof have been
registered under the Securities Act of 1933, as amended (the “Securities
Act”), as contemplated by the Registration Rights Agreement (as defined in
the Purchase Agreement), or the shares of Allora Stock or EPOD Stock issuable
upon Exercise hereof otherwise may be sold pursuant to Rule 144 or Rule 144(k)
under the Securities Act without any restriction as to the number of securities
as of a particular date that can then be immediately sold, the Exercise Shares
may bear a restrictive legend in substantially the following form (and a
stop-transfer order may be placed against transfer of the certificates for such
securities): 

5

  
         “THE SECURITIES REPRESENTED
      BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
      1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY
      NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
      STATEMENT FOR THE SECURITIES UNDER SAID ACT, OR AN OPINION OF COUNSEL, IN
      FORM, SUBSTANCE AND SCOPE REASONABLY SATISFACTORY TO COUNSEL TO THE COMPANY,
      THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR UNLESS SOLD PURSUANT
      TO RULE 144 UNDER SAID ACT.” 

  

                         (ii)
Removal of Restrictive Legends. With respect to any Exercise Shares
comprised of shares of Allora Stock (the “Allora Exercise Shares”),
certificates evidencing such Allora Exercise Shares shall not contain any legend
restricting the transfer thereof (including the legend set forth above in
subsection 2(g)(i)): (i) while a registration statement (including a
Registration Statement as defined in the Registration Rights Agreement) covering
the resale of such securities is effective under the Securities Act, or (ii)
following any sale of such Allora Exercise Shares pursuant to Rule 144, or (iii)
if such Allora Exercise Shares are eligible for sale under Rule 144(k), or (iv)
if such legend is not required under applicable requirements of the Securities
Act (including judicial interpretations and pronouncements issued by the staff
of the Commission) (collectively, the “Unrestricted Conditions”).
Exercise Shares comprised of shares of EPOD Stock (the “EPOD Exercise
Shares”) shall contain restrictive legends set forth above (as well as any
other legends required pursuant to the remaining Transaction Documents) and
shall be transferable by the Holder only pursuant to Rule 144 or another
exemption from the registration requirements of the Securities Act or applicable
state securities laws. Allora shall cause its counsel to issue a legal opinion
to the Transfer Agent promptly after the Effective Date (as defined below) of
the Registration Statement if required by the Transfer Agent to effect the
issuance of Allora Exercise Shares without a restrictive legend or removal of
the legend hereunder. If the Unrestricted Conditions are met at the time of
issuance or resale of Allora Exercise Shares, then such Allora Exercise Shares
shall be issued free of all legends. Allora agrees that following the Effective
Date, or at such time as the Unrestricted Conditions are met or such legend is
otherwise no longer required under this Section 2(g), it will, no later than
three (3) Business Days following the delivery (the “Unlegended Shares
Delivery Deadline”) by the Holder to Allora or the Transfer Agent of a
certificate representing such Allora Exercise Shares, as applicable, issued with
a restrictive legend (such third Business Day, the “Legend Removal
Date”), deliver, or cause the Transfer Agent to deliver at Allora’s expense,
to such Holder a certificate (or electronic transfer) representing such Allora
Exercise Shares that is free from all restrictive and other legends. For
purposes hereof, “Effective Date” shall mean the date that the Registration Statement that Allora is required to file pursuant
to the Registration Rights Agreement has been declared effective by the
Securities and Exchange Commission (the “Commission”).

6

                         (iii)
Sale of Unlegended Shares. Holder agrees that the removal of the
restrictive legend from certificates representing Allora Exercise Shares or EPOD
Exercise Shares, as applicable, as set forth in Section 2(g)(ii) above is
predicated upon Allora’s or the Company’s reliance, as applicable, that the
Holder will sell any such shares pursuant to either the registration
requirements of the Securities Act, including any applicable prospectus delivery
requirements, or an exemption therefrom, and that if such Allora Exercise Shares
are sold pursuant to a Registration Statement, they will be sold in compliance
with the plan of distribution set forth therein.

          (h)
Cancellation of Warrant. This Warrant shall be canceled upon the full
Exercise hereof, and, as soon as practical after the Date of Exercise, Holder
shall be entitled to receive shares of EPOD Stock or Allora Stock, as
applicable, for the number of shares purchased upon such Exercise of this
Warrant, and if this Warrant is not Exercised in full, Holder shall be entitled
to receive a new Warrant (containing terms identical to this Warrant)
representing any unexercised portion of this Warrant in addition to such shares
of EPOD Stock or Allora Stock, as applicable.

          (i)
Holder of Record. Each person in whose name any Warrant for shares of shares
of EPOD Stock or Allora Stock, as applicable, is issued shall, for all purposes,
be deemed to be the Holder of record of such shares on the Date of Exercise of
this Warrant, irrespective of the date of delivery of the shares of EPOD Stock
or Allora Stock, as applicable, purchased upon the Exercise of this Warrant.
Nothing in this Warrant shall be construed as conferring upon Holder any rights
as a stockholder of the Company or Allora, as applicable, until the Exercise of
this Warrant. 

          (j)
Delivery of Electronic Shares. In lieu of delivering physical
certificates representing any unlegended shares of Allora Stock issuable upon
Exercise (the “Unlegended Shares”), and provided the Transfer Agent is
participating in the Depository Trust Company (“DTC”) Fast Automated
Securities Transfer (“FAST”) program, upon written request of the Holder,
so long as the certificates therefor do not bear a legend, are not required to
bear a legend, and the Holder is not obligated to return such certificate for
the placement of a legend thereon, Allora shall cause the Transfer Agent to
electronically transmit the Unlegended Shares to the Holder by crediting the
account of the Holder's prime broker with DTC identified in the written request
through its Deposit Withdrawal Agent Commission (“DWAC”) system.
Otherwise, delivery of the Allora Stock shall be by physical delivery to the
address specified by the Holder in the Notice of Exercise. The time periods for
delivery and liquidated damages described herein shall apply to the electronic
transmittals described herein, or to physical delivery, whichever is
applicable.

          (k)
Buy-In. In addition to any other rights available to the Holder, if Allora
fails, or fails to cause the Transfer Agent to transmit to the Holder a
certificate or certificates representing the Exercise Shares pursuant to an
Exercise on or before the Exercise Shares Delivery Deadline, and if after such
date the Holder is required by its broker to purchase (in an open market
transaction or otherwise) or the Holder’s brokerage firm otherwise purchases shares of Allora Stock to deliver in
satisfaction of a sale by the Holder of the Exercise Shares which the Holder
anticipated receiving upon such Exercise (a “Buy-In”), then Allora shall
(1) pay in cash to the Holder the amount by which (x) the Holder’s total
purchase price (including brokerage commissions, if any) for the shares of
Allora Stock so purchased exceeds (y) the amount obtained by multiplying (A) the
number of shares of Allora Stock that Allora was required to deliver to the
Holder in connection with the Exercise at issue times (B) the price at which the
sell order giving rise to such purchase obligation was executed, and (2) at the
option of the Holder, either reinstate the portion of the Warrant and equivalent
number of shares of Allora Stock for which such Exercise was not honored (in
which case such Exercise shall be deemed rescinded) or deliver to the Holder the
number of shares of Allora Stock that would have been issued had Allora timely
complied with its Exercise and delivery obligations hereunder. For example, if
the Holder purchases Allora Stock having a total purchase price of $11,000 to
cover a Buy-In with respect to an attempted Exercise of shares of Allora Stock
with an aggregate sale price giving rise to such purchase obligation of $10,000,
under clause (1) of the immediately preceding sentence Allora shall be required
to pay the Holder $1,000. The Holder shall provide Allora written notice
indicating the amounts payable to the Holder in respect of the Buy-In, together
with applicable confirmations and other evidence reasonably requested by Allora.
Nothing herein shall limit a Holder’s right to pursue any other remedies
available to it hereunder, at law or in equity including, without limitation, a
decree of specific performance and/or injunctive relief with respect to Allora’s
failure to timely deliver certificates representing shares of Allora Stock upon
Exercise of the Warrant as required pursuant to the terms hereof. 

7

          (l)
Surrender of Warrant Upon Exercise; Book-Entry. Notwithstanding anything to
the contrary set forth herein, upon Exercise of this Warrant in accordance with
the terms hereof, the Holder shall not be required to physically surrender this
Warrant to the Company or Allora, as applicable, unless this Warrant is
Exercised in full, in which case such Holder shall deliver the original Warrant
being Exercised to the Company or Allora, as applicable, promptly following the
Date of Exercise at issue. Partial Exercises of this Warrant resulting in
purchases of a portion of the total number of Exercise Shares available upon
Exercise hereof shall have the effect of lowering the outstanding number of
Exercise Shares purchasable hereunder in an amount equal to the applicable
number of Exercise Shares purchased. The Holder and the Company or Allora, as
applicable, shall maintain records showing the amount of this Warrant that is so
Exercised and the dates of such Exercises or shall use such other method,
reasonably satisfactory to the Holder and the Company or Allora, as applicable,
so as not to require physical surrender of this original Warrant upon each such
Exercise. In the event of any dispute or discrepancy, such records of the Holder
shall be controlling and determinative in the absence of manifest error. The
Holder and any assignee, by acceptance of this Warrant, acknowledge and agree
that, by reason of the provisions of this paragraph, following the purchase of a
portion of the Exercise Shares hereunder, the number of Exercise Shares
available for purchase hereunder at any given time may be less than the amount
stated on the face hereof.

     3.     
Payment of Warrant Exercise Price. 

          The
Exercise Price (“Exercise Price”) shall initially be equal to the lesser
of (i) in the case of Exercise into either shares of Allora Stock or EPOD Stock,
$14.00 per share, or (ii) with respect solely to Exercise into shares of Allora
Stock if, at the time of delivery of an Exercise Notice to Allora, there are
quotations available in an Eligible Market with respect to shares of Allora
Stock, the closing price for the shares on the first Business Day such shares
are trading, less a twenty percent (20%) discount (the “Initial Exercise
Price”), subject to adjustment pursuant to the terms hereof, including but
not limited to Section 5 below.  

8

          Payment
of the Exercise Price may be made by either of the following, or a combination
thereof, at the election of Holder: 

                    (i)     
Cash Exercise: The Holder may Exercise this Warrant in
cash, bank or cashiers check or wire transfer (a “Cash Exercise”); or

                    (ii)      Cashless
Exercise: The Holder, at its option, may Exercise this Warrant in
whole or in part via cashless exercise (a “Cashless Exercise”) any time
that there is (x) not a current and effective Registration Statement (as defined
in the Registration Rights Agreement) covering the resale of the Allora Exercise
Shares issuable upon such Exercise, or (y) upon the occurrence of an Event of
Default. In order to effect a Cashless Exercise, the Holder shall
surrender of this Warrant at the principal office of the Company or Allora,
as applicable, together with notice of cashless election, in which event the
Company or Allora, as applicable, shall issue Holder a number of shares of EPOD
Stock or Allora Stock, as applicable, equal to the quotient obtained by dividing
[(Y)(A-B)] by A, where: 

          Y =
the number of shares of EPOD Stock or Allora Stock, as applicable, which would
be issuable upon Exercise of the Warrant if such Exercise were by means of a
Cash Exercise rather than a Cashless Exercise. 

A = the VWAP (as defined in the
Debentures) of one (1) share of Allora Stock, or of one (1) share of EPOD Stock,
as applicable of such shares during the five (5) consecutive Business Day period
immediately preceding the date of Exercise, or other applicable date. 

B = the Exercise Price. 

          For
purposes of Rule 144 and sub-section (d)(3)(ii) thereof, it is intended,
understood and acknowledged that the Exercise Shares issuable upon Exercise of
this Warrant in a cashless Exercise transaction shall be deemed to have been
acquired at the time this Warrant was issued. Moreover, it is intended,
understood and acknowledged that the holding period for the Exercise Shares
issuable upon Exercise of this Warrant in a cashless Exercise transaction shall
be deemed to have commenced on the date this Warrant was issued.

          4.      Transfer
and Registration. 

          (a)
Transfer Rights. Subject to the provisions of Section 8 of this Warrant,
this Warrant may be transferred on the books of the Company or Allora, as
applicable, in whole or in part, in person or by attorney, upon surrender of
this Warrant properly completed and endorsed together with a written form of
assignment in the form attached hereto as Exhibit B. This Warrant
shall be canceled upon such surrender and, as soon as practicable thereafter,
the person to whom such transfer is made shall be entitled to receive a new
warrant or warrants as to the portion of this Warrant transferred, and the
Holder shall be entitled to receive a new warrant as to the portion hereof
retained.

9

          (b)
Registrable Securities. The Allora Exercise Shares have registration
rights pursuant to that certain Registration Rights Agreement between Allora and
the Holder dated as of even date herewith. 

          (c)
Assignment and Assumption. As of the date of closing of the Asset
Purchase, this Warrant shall be irrevocably transferred to and assumed by
Allora, after which time the obligations and liabilities hereunder shall be the
joint obligations of the Company and Allora until such time as this Warrant is
fully Exercised by the Holder and all other obligations under this Warrant of
the Company or Allora, as applicable, are satisfied; provided, however, that in
the event that the closing of the Asset Purchase does not take place for any
reason, this Warrant may be Exercised by the Holder solely for shares of EPOD
Stock, and the obligations hereunder shall solely be those of EPOD. 

          5.     
Anti-Dilution Adjustments; Additional Adjustments; Purchase Rights.

          (a)
[Omitted].

          (b)
Recapitalization or Reclassification. If the Company or Allora, as
applicable, shall at any time effect a recapitalization, reclassification or
other similar transaction of such character that the shares of EPOD Stock or
Allora Stock, as applicable, shall be changed into or become exchangeable for a
larger or smaller number of shares, then upon the effective date thereof, the
number of shares of EPOD Stock or Allora Stock, as applicable, which Holder
shall be entitled to purchase upon Exercise of this Warrant shall be increased
or decreased, as the case may be, in direct proportion to the increase or
decrease in the number of shares of EPOD Stock or Allora Stock, as applicable,
by reason of such recapitalization, reclassification or similar transaction, and
the Exercise Price shall be, in the case of an increase in the number of shares,
proportionally decreased and, in the case of decrease in the number of shares,
proportionally increased. The Company or Allora, as applicable, shall give
Holder the same notice it provides to holders of EPOD Stock or Allora Stock, as
applicable, of any transaction described in this Section 5(b). 

          
(c) Exercise Price Adjusted. As used in this Warrant, the term
“Exercise Price” shall mean the purchase price per share specified in
Section 3 of this Warrant, until the occurrence of an event stated in this
Section 5 or otherwise set forth in this Warrant, and thereafter shall mean said
price as adjusted from time to time in accordance with the provisions of said
subsection. No such adjustment under this Section 5 shall be made unless such
adjustment would change the Exercise Price at the time by $.01 or more;
provided, however, that all adjustments not so made shall be deferred and made
when the aggregate thereof would change the Exercise Price at the time by $.01
or more. No adjustment made pursuant to any provision of this Section 5 shall
have the net effect of increasing the Exercise Price in relation to the split
adjusted and distribution adjusted price of the shares of EPOD Stock or Allora
Stock, as applicable, issuable upon Exercise.

10

          (d)
Adjustments: Additional Shares, Securities or Assets. In the event that at
any time, as a result of an adjustment made pursuant to this Section 5 or
otherwise, Holder shall, upon Exercise of this Warrant, become entitled to
receive shares and/or other securities or assets (other than shares of EPOD
Stock or Allora Stock, as applicable) then, wherever appropriate, all references
herein to shares of EPOD Stock or Allora Stock, as applicable, shall be deemed
to refer to and include such shares and/or other securities or assets; and
thereafter the number of such shares and/or other securities or assets shall be
subject to adjustment from time to time in a manner and upon terms as nearly
equivalent as practicable to the provisions of this Section 5.

          (e)
Adjustment Upon Issuance of Shares of Common Stock or Common Stock
Equivalents. If the Company or Allora, as applicable, issues or sells, or in
accordance with this Section 5(e) is deemed to have issued or sold, any shares
of EPOD Stock or Allora Stock, as applicable (including the issuance or sale of
such shares owned or held by or for the account of the Company or Allora, as
applicable, but excluding any such shares deemed to have been issued by the
Company or Allora, as applicable, in connection with an Exempt Issuance (as
defined in the Debentures) for a consideration per share (the “New Issuance
Price”) less than a price (the “Applicable Price”) equal to the
Exercise Price in effect immediately prior to such issue or sale or deemed
issuance or sale (the foregoing a “Dilutive Issuance”), then immediately
after such Dilutive Issuance, the Exercise Price then in effect shall be reduced
to an amount equal to the New Issuance Price. Upon each such adjustment of the
Exercise Price hereunder, the number of Exercise Shares shall be adjusted in
accordance with Section 5(k) below. The adjustments required by this paragraph
and by Sections 5(e)(i)-(iv) below are referred to in the singular, as a
“Subsequent Issuance Adjustment” and, collectively, as “Subsequent
Issuance Adjustments”. No such Subsequent Issuance Adjustment pursuant to
this Section 5(e) shall be made if such adjustment would result in an increase
in the then effective Exercise Price or a decrease in the number of Exercise
Shares. For purposes of determining the adjusted Exercise Price under this
Section 5(e), the following shall be applicable: 

                         (i)
  Issuance of Options. If the Company or Allora, as applicable, in any
  manner grants any Options and the lowest price per share for which one share
  of EPOD Stock or Allora Stock, as applicable, is issuable upon the exercise
  of any such Option or upon conversion, exercise or exchange of any Convertible
  Securities issuable upon exercise of any such Option is less than the Applicable
  Price, then such share of EPOD Stock or Allora Stock, as applicable, shall be
  deemed to be outstanding and to have been issued and sold by the Company or
  Allora, respectively, at the time the granting or sale of such Option for such
  price per share was approved by the board of directors of the Company or Allora,
  as applicable.

                         (ii)
Issuance of Convertible Securities. If the Company or Allora, as
applicable, in any manner issues or sells any Convertible Securities and the
lowest price per share for which one share of EPOD Stock or Allora Stock,
respectively, is issuable upon the conversion, exercise or exchange thereof is
less than the Applicable Price, then such share of EPOD Stock or Allora Stock,
as applicable, shall be deemed to be outstanding and to have been issued and
sold by the Company or Allora, as applicable, at the time of the issuance or
sale of such Convertible Securities for such price per share. For the purposes of this Section 5(e)(ii), the “lowest price per
share for which one share of EPOD Stock or Allora Stock, as applicable, is
issuable upon the conversion, exercise or exchange” shall be equal to the lowest
amount of consideration (if any) received, to be received or receivable by the
Company or Allora, as applicable, with respect to one share of EPOD Stock or
Allora Stock, respectively, upon the issuance or sale of the Convertible
Security and upon conversion, exercise or exchange of such Convertible Security.
In the case of a Convertible Security which is accompanied by Options
(collectively, a “Unit”), the “lowest price per share for which one share
of EPOD Stock or Allora Stock, as applicable, is issuable upon the conversion,
exercise or exchange of such Convertible Security” shall equal (i) the
consideration deemed received in exchange for the Convertible Security, as
determined in accordance with subsection 5(e)(iv) below, divided by (ii) the
total number of shares into which such Convertible Security is convertible or
exchangeable (notwithstanding any contractual limitation on the timing or amount
of conversions).

11

                         (iii)
Change in Option Price or Rate of Conversion. If the purchase price
provided for in any Option, the additional consideration, if any, payable upon
the issue, conversion, exercise or exchange of any Convertible Securities, or
the rate at which any Convertible Securities are convertible into or exercisable
or exchangeable for shares of EPOD Stock or Allora Stock, as applicable,
increases or decreases at any time, the Exercise Price and the number of
Exercise Shares in effect at the time of such increase or decrease shall be
adjusted to the Exercise Price and the number of Exercise Shares which would
have been in effect at such time had such Options or Convertible Securities
provided for such increased or decreased purchase price, additional
consideration or increased or decreased conversion rate, as the case may be, at
the time such Options or Convertible Securities were initially granted, issued
or sold. For purposes of this Section 5(e)(iii), if the terms of any Option or
Convertible Security that was outstanding as of the date of issuance of this
Warrant are increased or decreased in the manner described in the immediately
preceding sentence, then such Option or Convertible Security and the shares of
EPOD Stock or Allora Stock, as applicable, deemed issuable upon exercise,
conversion or exchange thereof shall be deemed to have been issued as of the
date of such increase or decrease. No adjustment pursuant to this Section
5(e)(iii) shall be made if such adjustment would result in an increase of the
Exercise Price then in effect or a decrease in the number of Exercise Shares.

                         (iv)
Calculation of Consideration Received. In case any Option is issued in
connection with the issue or sale of other securities of the Company or Allora,
as applicable, together comprising one integrated transaction, the Options will
be deemed to have been issued at the lowest price per Option actually received
by the Company or Allora, as applicable, and the other securities issued or sold
in such integrated transaction will be deemed to have been issued or sold for
the balance of the consideration received by the Company or Allora, as
applicable. If any shares of EPOD Stock or Allora Stock, as applicable, or
Options or Convertible Securities therefor are issued or sold or deemed to have
been issued or sold for cash, the consideration received therefor will be deemed
to be the gross amount received by the Company or Allora, as applicable,
therefor. If any shares of EPOD Stock or Allora Stock, as applicable, Options or
Convertible Securities therefor are issued or sold for a consideration other
than cash, the amount of such consideration received by the Company or Allora,
as applicable, will be the fair value of such consideration, except where such
consideration consists of securities, in which case the gross amount of consideration received by the Company or
Allora, as applicable, will be the VWAP of such security on the date of receipt.
If any shares of EPOD Stock or Allora Stock, as applicable, or Options or
Convertible Securities therefor are issued to the owners of the non-surviving
entity in connection with any merger in which the Company or Allora, as
applicable, is the surviving entity, the amount of consideration therefor will
be deemed to be the fair value of such portion of the net assets and business of
the non-surviving entity as is attributable to such shares of EPOD Stock or
Allora Stock, as applicable, or Options or Convertible Securities therefor, as
the case may be. The fair value of any consideration other than cash or
securities will be determined jointly by the Company or Allora, as applicable,
on the one hand, and the Required Warrant Holders, on the other hand. If such
parties are unable to reach agreement within ten (10) days after the occurrence
of an event requiring valuation (the “Valuation Event”), the fair value
of such consideration will be determined within five (5) Business Days after the
tenth day following the Valuation Event by an independent, reputable appraiser
jointly selected by the Company or Allora, as applicable, and the Required
Warrant Holders. The determination of such appraiser shall be final and binding
upon all parties absent manifest error and the fees and expenses of such
appraiser shall be borne by the Company or Allora, as applicable. 

12

                         (v)
  Record Date. If the Company or Allora, as applicable, takes a record
  of the holders of shares of EPOD Stock or Allora Stock, as applicable, for the
  purpose of entitling them (i) to receive a dividend or other distribution payable
  in shares of EPOD Stock or Allora Stock, as applicable, or in Options or Convertible
  Securities, or (ii) to subscribe for or purchase shares of EPOD Stock or Allora
  Stock, as applicable, or in Options or Convertible Securities, then such record
  date will be deemed to be the date of the issue or sale of the shares of EPOD
  Stock or Allora Stock, as applicable, deemed to have been issued or sold upon
  the declaration of such dividend or the making of such other distribution or
  the date of the granting of such right of subscription or purchase, as the case
  may be.

          For
purposes hereof: 

          “Common
Stock Equivalents,” “Exempt Issuance” “Convertible Securities” “Options”
and “Variable Equity Securities” shall each have the meanings
ascribed to them in the Debentures. 

          (f)
Subsequent Rights Offerings. If the Company or Allora, as applicable, at
anytime prior to the date that all of the Warrants have been Exercised, redeemed
or otherwise satisfied in accordance with their terms, shall issue rights,
options or warrants to all holders of EPOD Stock or Allora Stock, as applicable
(and not to Holders), entitling them to subscribe for or purchase shares of EPOD
Stock or Allora Stock, as applicable, at a price per share (the “Base Rights
Offering Price”) that is lower than the Applicable Price, then the Exercise
Price then in effect shall be reduced (but not increased) to the Base Rights
Offering Price (a “Subsequent Rights Offering Adjustment”). Such
adjustment shall be made whenever such rights or warrants are issued, and shall
become effective immediately after the record date for the determination of
stockholders entitled to receive such rights, options or warrants. No adjustment
shall be made hereunder if such adjustment would result in an increase of the
Exercise Price then in effect. 

13

          (g)
Pro Rata Distributions. If the Company or Allora, as applicable, at anytime
prior to the date that all of the Warrants have been Exercised, redeemed or
otherwise satisfied in accordance with their terms, shall distribute to all
holders of EPOD Stock or Allora Stock, as applicable (and not to the Holders),
evidences of indebtedness or assets (including cash and cash dividends) or
rights or warrants to subscribe for or purchase any security other than EPOD
Stock or Allora Stock, as applicable, entitling them to subscribe for or
purchase shares of EPOD Stock or Allora Stock, as applicable, then in each case
the Exercise Price then in effect shall be adjusted by multiplying the Exercise
Price in effect immediately prior to the record date fixed for determination of
stockholders entitled to receive such distribution by a fraction of which the
denominator shall be the VWAP determined as of the record date mentioned above,
and of which the numerator shall be such VWAP on such record date less the then
per share fair market value at such record date of the portion of such assets or
evidence of indebtedness or rights or warrants so distributed applicable to one
outstanding share of the EPOD Stock or Allora Stock, as applicable, as
determined by the board of directors in good faith. In either case the
adjustments shall be described in a statement provided to the Holder of the
portion of assets or evidences of indebtedness so distributed or such
subscription rights applicable to one share of EPOD Stock or Allora Stock, as
applicable. Such adjustment shall be made whenever such distribution is made,
and shall become effective immediately after the record date mentioned above. No
adjustment shall be made hereunder if such adjustment would result in an
increase of the Exercise Price then in effect. 

          (h)
  Stock Dividends and Splits. If the Company or Allora, at any time while
  this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a
  distribution or distributions on shares of EPOD Stock or Allora Stock, as applicable,
  any other equity or equity equivalent securities payable in shares of EPOD Stock
  or Allora Stock, as applicable, (which, for avoidance of doubt, shall not include
  any shares of Common Stock issued upon Exercise of this Warrant), (ii) subdivides
  outstanding shares of EPOD Stock or Allora Stock, as applicable, into a larger
  number of shares, (iii) combines (including by way of reverse stock split) outstanding
  shares of EPOD Stock or Allora Stock, as applicable, into a smaller number of
  shares or (iv) issues by reclassification of shares of EPOD Stock or Allora
  Stock, as applicable, any shares of capital stock of the Company, then in each
  case the Exercise Price shall be multiplied by a fraction of which the numerator
  shall be the number of shares of EPOD Stock or Allora Stock, as applicable,
  outstanding immediately before such event and of which the denominator shall
  be the number of shares of EPOD Stock or Allora Stock, as applicable, outstanding
  immediately after such event, and the number of shares issuable upon Exercise
  of this Warrant shall be proportionately adjusted such that the aggregate Exercise
  Price of this Warrant shall remain unchanged. Any adjustment made pursuant to
  this Section 5(g) shall become effective immediately after the record date for
  the determination of stockholders entitled to receive such dividend or distribution
  and shall become effective immediately after the effective date in the case
  of a subdivision, combination or re-classification.

          (i)
Voluntary Adjustment By Company. The Company or Allora, as applicable, may
at any time during the term of this Warrant reduce the then current Exercise
Price to any amount and for any period of time deemed appropriate by the Board
of Directors of the Company or Allora, as applicable (a “Voluntary
Adjustment”). 

14

          (j)
Adjustment to Number of Shares. In the event of any adjustment to the
Exercise Price pursuant to the terms of this Warrant, including but not limited
to any Subsequent Issuance Adjustment any Subsequent Rights Offering Adjustment,
or any Voluntary Adjustment, the number of Exercise Shares issuable upon
Exercise of this Warrant shall be increased such that the aggregate Exercise
Price payable in a full Cash Exercise hereunder, after taking into account the
decrease in the Exercise Price, shall be equal to the aggregate Exercise Price
payable in a full Cash Exercise prior to such adjustment, and the number of
Exercise Shares issuable in a cashless Exercise shall be increased in the same
manner.

          (k)
Notice of Dilutive Issuances and Adjustments; Notice Failure Adjustment.
The Company or Allora, as applicable, shall notify the Holder in writing,
no later than one (1) Business Day following any Dilutive Issuance, indicating
therein the applicable issuance price, or applicable reset price, exchange
price, conversion price, exercise price and other pricing terms (such notice,
the “Dilutive Issuance Notice”). In the event that the Company or Allora,
as applicable, fails to provide the Holder with an Exercise Price Adjustment
Notice within five (5) Business Days of any Dilutive Issuance (the “Dilutive
Issuance Notice Deadline”), the Exercise Price shall be permanently reduced
(but not increased) on the Dilutive Issuance Notice Deadline, and on the same
day of each calendar month thereafter until such notice is given (each, a
“Notice Failure Adjustment Date”), or in each case if not a Business Day,
then on the next Business Day (each, a “Notice Failure Adjustment”) to a
price equal to the lesser of (a) the Exercise Price then in effect or (b) 100%
of the Volume Weighted Average Price for the five (5) Business Day period
immediately preceding the applicable Notice Failure Adjustment Date
(collectively, the “Notice Failure Adjustment Price”). 

          Whenever
  the Exercise Price is required to be adjusted pursuant to the terms of this
  Warrant, the Company or Allora, as applicable, shall promptly mail to the Holder
  a notice (a “Exercise Price Adjustment Notice”) setting forth
  the new Exercise Price and specifying the new number of shares into which the
  Warrant is exercisable after such adjustment and setting forth a statement of
  the facts requiring such adjustment. The Company or Allora, as applicable, shall,
  upon the written request at any time of the Holder, furnish to such Holder a
  like Warrant setting forth (i) such adjustment or readjustment, (ii) the Exercise
  Price at the time in effect, and (iii) the number of shares of EPOD Stock or
  Allora Stock, as applicable, and the amount, if any, of other securities or
  property which at the time would be received upon Exercise of the Warrant, following
  delivery of the original Warrant to the Company or Allora, as applicable, for
  exchange. For purposes of clarification, whether or not the Company or Allora,
  as applicable, provides an Exercise Price Adjustment Notice pursuant to this
  Section 5(l), upon the occurrence of any event that leads to an adjustment of
  the Exercise Price, the Holders are entitled to receive an Exercise Price and
  a number of Exercise Shares based upon the new Exercise Price, as adjusted,
  for Exercises occurring on or after the date of such adjustment, regardless
  of whether a Holder accurately refers to the adjusted Exercise Price in the
  Notice of Exercise.

          (l)
Notice to Allow Exercise by Holder. If (A) the Company or Allora, as
applicable, shall declare a dividend (or any other distribution in whatever
form) on the shares of EPOD Stock or Allora Stock, respectively; (B) the Company
or Allora, as applicable, shall declare a special nonrecurring cash dividend on
or a redemption of the EPOD Stock or the Allora Stock, respectively; (C) the Company
or Allora, as applicable, shall authorize the granting to all holders of the
EPOD Stock or Allora Stock, respectively, rights or warrants to subscribe for or
purchase any shares of capital stock of any class or of any rights; (D) the
approval of any stockholders of the Company or Allora, as applicable, shall be
required in connection with any reclassification of the EPOD Stock or Allora
Stock, as applicable, any consolidation or merger to which the Company or
Allora, as applicable, is a party, any sale or transfer of all or substantially
all of the assets of the Company or Allora, as applicable, of any compulsory
share exchange whereby the EPOD Stock or Allora Stock, as applicable, is
converted into other securities, cash or property; (E) the Company or Allora, as
applicable, shall authorize the voluntary or involuntary dissolution,
liquidation or winding up of the affairs of the Company or Allora, as
applicable; then, in each case, the Company or Allora, as applicable, shall
cause to be filed at each office or agency maintained for the purpose of
Exercise of this Warrant, and shall cause to be delivered to the Holder at its
last address as it shall appear upon the Warrant Register of the Company
or Allora, as applicable, at least 20 calendar days prior to the applicable
record or effective date hereinafter specified, a notice stating (x) the date on
which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as
of which the holders of the EPOD Stock or Allora Stock, as applicable, of record
to be entitled to such dividend, distributions, redemption, rights or warrants
are to be determined, or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become
effective or close, and the date as of which it is expected that holders of the
EPOD Stock or Allora Stock, as applicable, of record shall be entitled to
exchange their shares of the EPOD Stock or Allora Stock, as applicable, for
securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the
failure to deliver such notice or any defect therein or in the delivery thereof
shall not affect the validity of the corporate action required to be specified
in such notice. To the extent that any notice provided hereunder constitutes, or
contains, material, non-public information regarding Allora or any of its
subsidiaries, Allora shall simultaneously file such notice with the Commission
pursuant to a Current Report on Form 8-K. The Holder is entitled to Exercise
this Warrant during the period commencing on the date of such notice to the
effective date of the event triggering such notice. 

15

          (m)
Purchase Rights. In addition to any other adjustments described
herein, if at any time the Company or Allora, as applicable, grants, issues or
sells any Options, Convertible Securities or rights to purchase stock, warrants,
securities or other property pro rata to the record holders of any class of
shares of EPOD Stock or Allora Stock, as applicable (the “Purchase
Rights”), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the
Holder could have acquired if the Holder had held the proportionate number of
shares of EPOD Stock or Allora Stock, as applicable, acquirable upon complete
Exercise of this Warrant (without regard to any limitations on the Exercise of
this Warrant) immediately before the date on which a record is taken for the
grant, issuance or sale of such Purchase Rights, or, if no such record is taken,
the date as of which the record holders of shares of EPOD Stock or Allora Stock,
as applicable, are to be determined for the grant, issue or sale of such
Purchase Rights. 

16

          6.     
Fractional Interests. 

          No
fractional shares or scrip representing fractional shares shall be issuable upon
the Exercise of this Warrant. If, upon Exercise of this Warrant, Holder would be
entitled to a fractional share of EPOD Stock or Allora Stock, as applicable, or
a right to acquire a fractional share of EPOD Stock or Allora Stock, as
applicable, such fractional share shall be disregarded and the number of shares
of EPOD Stock or Allora Stock, as applicable, issuable upon Exercise shall be
rounded up to the next whole share. 

          7.     
Reservation of Shares. 

          The
Company and Allora, as and to the extent applicable, covenant that each of them
will, during the Term of this Warrant, reserve (the “Initial Share
Reservation”), from their respective authorized and unissued common stock, a
sufficient number of shares of common stock equal to at least the Required
Minimum in accordance with Section 7.08 of the Purchase Agreement. The Company
and Allora, as and to the extent applicable, shall authorize and reserve such
additional amounts (the “Required Reserve Amount”) of shares from time to
time as necessary to comply with the Company’s and Allora’s obligations, as
applicable, to meet the Required Minimum. The Company and Allora, as applicable,
further covenant that the issuance of this Warrant shall constitute full
authority to its officers who are charged with the duty of executing stock
certificates to execute and issue the necessary certificates for the Exercise
Shares upon the Exercise of the purchase rights under this Warrant. The Company
and Allora, as applicable, will take all such reasonable action as may be
necessary to assure that such Exercise Shares may be issued as provided herein
without violation of any applicable law or regulation, or of any requirements of
an Eligible Market upon which such shares may be listed. The Company and Allora,
as and to the extent applicable, represent that, upon issuance, such shares will
be duly authorized, validly issued, fully paid and non-assessable and free from
all taxes, liens and charges created by the Company or Allora, as applicable, in
respect of the issue thereof. In addition, if the Company or Allora, as
applicable, shall issue any securities or make any change to its capital
structure which would change the number of shares of EPOD Stock or Allora Stock,
as applicable, into which this Warrant shall be Exercisable at the then
applicable Exercise Price, or if the Exercise Price shall be adjusted, the
Company or Allora, as applicable, shall at the same time make proper provision
so that thereafter there shall be a sufficient number of shares of EPOD Stock or
Allora Stock, as applicable, authorized and reserved, free from preemptive
rights, for Exercise of this Warrant. 

          8.     
Restrictions on Transfer. 

                    (a)
Registration or Exemption Required. This Warrant has been issued in a
transaction exempt from the registration requirements of the Securities Act by
virtue of Regulation D promulgated thereunder, and exempt from state
registration under applicable state laws. The Warrant and the Exercise Shares
issuable upon the Exercise of this Warrant may not be transferred, sold or
assigned except pursuant to an effective registration statement or an exemption
to the registration requirements of the Securities Act and applicable state
laws. Upon such surrender, the Company shall execute and deliver a new Warrant
or Warrants in the name of the assignee or assignees, as applicable, and in the
denomination or denominations specified in such instrument of assignment, and
shall issue to the assignor a new Warrant evidencing the portion of this Warrant
not so assigned, and this Warrant shall promptly be cancelled. The Warrant, if
properly assigned in accordance herewith, may be Exercised by a new holder for
the purchase of Exercise Shares without having a new Warrant issued. 

17

                    (b)
Assignment. If Holder can provide the Company or Allora, as applicable,
with reasonably satisfactory evidence that the conditions of Section 8(a) above
regarding registration or exemption have been satisfied, Holder may sell,
transfer, assign, pledge or otherwise dispose of this Warrant, in whole or in
part. Holder shall deliver a written notice to the Company or Allora, as
applicable, substantially in the form of the Assignment attached hereto as
Exhibit B, indicating the person or persons to whom the Warrant shall be
assigned and the respective number of warrants to be assigned to each assignee.
The Company or Allora, as applicable, shall effect the assignment within ten
(10) Business Days of receipt of such notice, and shall deliver to the
assignee(s) designated by Holder a Warrant or Warrants of like tenor and terms
for the appropriate number of Exercise Shares. 

          9.      Noncircumvention.
The Company or Allora, as and to the extent applicable, hereby covenants and
agrees that neither of them will by any action including, without limitation, by
amendment of its Certificate of Incorporation, Bylaws or other organizational
documents, through any reorganization, transfer of assets, consolidation,
merger, scheme of arrangement, dissolution, issue or sale of securities, or any
other voluntary action, avoid or seek to avoid the observance or performance of
any of the terms of this Warrant, and will at all times in good faith carry out
all the provisions of this Warrant and take all action as may be required to
protect the rights of the Holder, as set forth in this Warrant, against
impairment. Without limiting the generality of the foregoing, the Company and
Allora, as applicable, (i) shall not increase the par value of any shares of
EPOD Stock or Allora Stock, as applicable, receivable upon the Exercise of this
Warrant above the Exercise Price then in effect, (ii) shall take all such
actions as may be necessary or appropriate in order that the Company or Allora,
as applicable, may validly and legally issue fully paid and nonassessable shares
of EPOD Stock or Allora Stock, as applicable, upon the Exercise of this Warrant,
and (iii) shall use commercially reasonable efforts to obtain all such
authorizations, exemptions or consents from any public regulatory body having
jurisdiction thereof, as may be, necessary to enable the Company or Allora, as
applicable, to perform its obligations under this Warrant. Before taking any
action which would result in an adjustment in the number of Exercise Shares for
which this Warrant is exercisable or to the Exercise Price, the Company shall
obtain all such authorizations or exemptions thereof, or consents thereto, as
may be necessary from any public regulatory body or bodies having jurisdiction
thereof. 

          10.     
Rights Upon Major Transaction or Change of Entity Transaction. 

                    (a)
  Definitions. For purposes hereof, 

          “Change
of Entity Transaction” means a consolidation, merger, exchange of shares,
recapitalization, reorganization, business combination or other similar event,
in one or a series of transactions, with a publicly-traded company current in
its 1934 Act filings and requirements, following which (a) the holders of EPOD
Stock or Allora Stock, as applicable, immediately preceding such
consolidation, merger, change of shares, recapitalization, reorganization,
business combination or event either (i) no longer hold a majority of the shares
of EPOD Stock or of Allora Stock, as applicable, or (ii) no longer have the
ability to elect a majority of the board of directors of the Company or of
Allora, as applicable, or (b) as a result of which shares of EPOD Stock or
Allora Stock, as applicable, shall be changed into (or the shares of EPOD Stock
or Allora Stock, as applicable, become entitled to receive) the same or a
different number of shares of the same or another class or classes of stock or
securities of the Company or Allora, as applicable, or another entity. For the
avoidance of doubt, the term Change of Entity Transaction, as used herein, shall
not include the Asset Purchase. 

18

          “Sufficient
Trading Characteristics” shall mean that the average daily dollar trading
volume of the common stock of such entity on its primary exchange or market is
equal to or in excess of $100,000 for the 90th through the 31st day prior to the
public announcement of the transaction in respect of which this definition shall
be applied. 

          “Permissible
Change of Entity Transaction” shall mean a Change of Entity Transaction
where the Successor Entity (as defined below) (A) is a publicly traded company
whose common stock is quoted on or listed for trading on an Eligible Market, (B)
has Sufficient Trading Characteristics (as defined above), and (C) meets the
Assumption Requirements (as required in Section 4(b) below), or any other Change
of Entity Transaction with respect to which the Holder provides the Company or
Allora, as applicable, with a Major Transaction Approval Notice (as defined in
subsection (d) immediately below). 

          “Eligible
  Market” means the over the counter Bulletin Board (“OTC-BB”),
  the New York Stock Exchange, Inc., the NASDAQ Capital Market, the NASDAQ Global
  Market, the NASDAQ Global Select Market or the NYSE Amex.

          “Impermissible
Change of Entity Transaction” shall mean a Change of Entity Transaction
which does not qualify as a Permissible Change of Entity Transaction. 

          “Major
Transaction” means

          (i)     
an Impermissible Change of Entity Transaction; and 

          (ii)      a
single or series of transactions through which the sale or transfer of more than
thirty three percent (33%), in the aggregate, of the properties or assets of the
Company or Allora, as applicable, including but not limited to the voting
securities of the Company or Allora, as applicable, to another Person or Persons
in any rolling 24 month period; and 

19

          (iii)     
a purchase, tender or exchange offer made to and accepted by the holders of more
than the 50% of the outstanding voting shares of EPOD Stock or Allora Stock, as
applicable. 

                         (b)
Assumption Upon Permissible Change of Entity Transaction. Neither the
Company nor Allora, as applicable, shall, for so long as any portion of this
Warrant remains outstanding, enter into or be party to a Change of Entity
Transaction unless any Person purchasing the Company’s assets or EPOD Stock, or
Allora’s assets or Allora Stock, as applicable, or unless any successor entity
resulting from such Change of Entity Transaction (in each case, a “Successor
Entity”) assumes (an “Assumption”), in writing, all of the
obligations of the Company or Allora, as applicable, under this Warrant and the
other Transaction Documents in accordance with the provisions of this Section
10(b) pursuant to written agreements in form and substance satisfactory to the
Required Warrant Holders (as defined below) and approved by the Required Warrant
Holders prior to such Change of Entity Transaction, including agreements to
deliver to each holder of Warrants in exchange for such Warrants a security of
the Successor Entity evidenced by a written instrument substantially similar in
form and substance to this Warrant, including, without limitation, having an
exercise price equal to the Exercise Price of this Warrant, having similar
exercise rights as this Warrant (including but not limited to similar exercise
price adjustment provisions, but not including the right to exercise the Warrant
into shares of EPOD Stock or Allora Stock, as applicable, if and to the extent
that it is not a party to the Change of Entity Transaction), and reasonably
satisfactory to the Required Warrant Holders. Upon the occurrence of any Change
of Entity Transaction, the Successor Entity shall succeed to, and be substituted
for (so that from and after the date of such Change of Entity Transaction, the
provisions of this Warrant referring to the “Company” or “Allora”, as
applicable, shall refer instead to the Successor Entity), and may exercise every
right and power of the Company or Allora, as applicable, and shall assume all of
the obligations of the Company or Allora, as applicable, under this Warrant with
the same effect as if such Successor Entity had been named herein. Upon
consummation of a Change of Entity Transaction, the Successor Entity shall
deliver to the Holder confirmation that there shall be issued upon Exercise or
redemption of the Warrants at any time after the consummation of the Change of
Entity Transaction, in lieu of the shares of EPOD Stock or Allora Stock, as
applicable (or other securities, cash, assets or other property) issuable upon
the Exercise of the Warrants prior to such Change of Entity Transaction, such
shares of publicly-traded common stock (or their equivalent) of the Successor
Entity, as adjusted in accordance with the provisions of this Warrant. The
provisions of this Section 10(b) shall apply similarly and equally to successive
Change of Entity Transactions and shall be applied without regard to any
limitations on the Exercise of the Warrant. The requirements of this Section
10(b) are referred to herein as the “Assumption Requirements.” 

          For
purposes hereof, “Required Warrant Holders” shall mean the Holders of
greater than seventy five percent (75%) of the then outstanding Warrants
(determined by the number of unexercised underlying shares). 

                         (c)
Notice of Major Transaction; Redemption Right Upon Major Transaction. At
least thirty (30) days prior to the consummation of a Major Transaction or
Change of Entity Transaction, the Company or Allora, as applicable, shall
deliver written notice thereof via facsimile and overnight courier to the Holder
(a “Major Transaction Notice”), which notice shall specify the nature and terms of the proposed
transaction (including notice of whether or not such transaction constitutes a
Major Transaction) and the nature of the Successor Entity (if any).

20

                         (d)
Redemption Right Upon Major Transaction. At any time during the period
beginning after the Holder's receipt of a Major Transaction Notice and ending on
the Business Day immediately prior to the consummation of such Major
Transaction, the Holder may require the Company or Allora, as applicable, to
redeem all or any portion of the Holder’s Warrant by delivering written notice
thereof (“Major Transaction Redemption Notice”) to the Company or Allora,
as applicable, which Major Transaction Redemption Notice shall indicate the
number of Exercise Shares of its Warrant (the “Redemption Warrant
Amount”) that the Holder is electing to be redeemed. The Redemption
Principal Amount of this Warrant subject to redemption pursuant to this Section
10(d) shall be redeemed by the Company or Allora, as applicable, in cash at a
price (the “Major Transaction Redemption Price”) equal to the greater of:

(i) the product of (A) the sum of the
Redemption Warrant Amount being redeemed and any accrued and unpaid liquidated
damages and any other Failure Payments (such amounts in addition to the
Redemption Warrant Amount are referred to herein as the “Supplementary
Amounts”), and (B) the quotient determined by dividing (x) the greater of
(I) the Market Price (as defined in the Debentures) of the shares of EPOD Stock
or Allora Stock immediately following the public announcement of such proposed
Major Transaction, and (II) such Market Price on the date that the Major
Transaction Redemption Price is paid to the Holder, by (y) the Exercise Price
then in effect;

and

(ii) the sum of (A) the Major
Transaction Redemption Price multiplied by the Redemption Warrant Amount being
redeemed, plus (B) the Supplementary Amounts.

                         (e)
Escrow; Payment of Major Transaction Redemption Price. Neither the
Company nor Allora, as applicable, shall effect a Major Transaction unless it
shall first place, or shall cause the Successor Entity to place, into an escrow
account with an independent escrow agent, prior to or concurrently with the
closing date of the Major Transaction (the “Major Transaction Escrow
Deadline”), an amount equal to the Major Transaction Redemption Price.
Concurrently upon closing of any Major Transaction, the Company shall pay or
shall instruct the escrow agent to pay the Major Transaction Redemption Price to
the Holder, which payment shall constitute a Redemption Upon Major Transaction
of the Warrants.

                         (f)
Injunction. In the event that the Company or Allora, as applicable,
attempts to consummate a Major Transaction without placing the Major Transaction
Redemption Price in escrow in accordance with subsection (e) above or without
payment of the Major Transaction Redemption Price to the Holder upon
consummation of such Major Transaction, the Holder shall have the right to apply for an
injunction in any state or federal courts sitting in the State of Delaware to
prevent the closing of such Major Transaction until the Major Transaction
Redemption Price is paid to the Holder, in full. 

21

                         (g)
Mechanics of Redemptions Upon Major Transactions. Redemptions required by
this Section 10 shall be made in accordance with the provisions of Section 12
and shall have priority to payments to shareholders of the Company or Allora, as
applicable, in connection with a Major Transaction. Notwithstanding anything to
the contrary in this Section 10, until the Major Transaction Redemption Price
(together with any Supplementary Amounts thereon) is paid in full, the
Redemption Warrant Amount submitted for redemption under this Section and the
Supplementary Amounts may be Exercised (a “Major Transaction Exercise”),
in whole or in part, by the Holder into shares of EPOD Stock or Allora Stock, as
applicable, upon written notice (“Major Transaction Exercise Notice”) to
the Company or Allora, as applicable (or the Successor Entity, if applicable),
or in the event the Exercise Date is after the consummation of a Change of
Entity Transaction (as defined above), into shares of publicly traded common
stock (or their equivalent) of the Successor Entity pursuant to Section 10(b).
Unless otherwise indicated by the Holder in the applicable Notice of Exercise,
any amount of this Warrant Exercised during the period from the date of the
Major Transaction Redemption Notice until the date the Major Transaction
Redemption Price is paid in full shall be considered to be an Exercise (instead
of a Redemption) of a portion of the Warrant that would have been subject to
such Redemption, and any amounts of this Warrant Exercised from time to time
during such period shall be Exercised in full into shares of EPOD Stock or
Allora Stock, as applicable, at the Exercise Price then in effect, and the
number of shares of this Warrant so Exercised shall be deducted from the
Redemption Warrant Amount (as defined above) and any Supplementary Amounts that
are subject to such redemption.

          11.     
Default and Redemption.

                         (a)
Events of Default. Each of the following events which occur while any
Warrants are outstanding shall be considered to be an “Event of
Default”: 

                              (i)
Failure To File and Pursue Registration. An Event of Default
occurs under Section 10(c) of the Debentures, with respect to any Exercise
Shares (a “Registration Default”); 

                              (ii)
Failure To Authorize and Reserve Common Stock. The Company or Allora, as
applicable, fails to authorize the Initial Share Reservation or maintain the
Required Reserve Amount, as applicable, pursuant to Section 7 (a “Share
Authorization Failure”), and such Share Authorization Failure remains
uncured for a period of more than twenty (20) days (a “Share Reservation
Default”); 

                              (iii)
Failure To Deliver Common Stock. An Exercise Shares Delivery Failure (as
defined above) occurs and remains uncured for a period of more than twenty (20)
days.

22

                         (iv)
Legend Removal Failure. A Legend Removal Failure occurs and remains
uncured for a period of five (5) Business Days, where a “Legend Removal
Failure” shall be deemed to have occurred if Allora fails to issue Allora
Exercise Shares without a restrictive legend. 

                         (v)
  Corporate Existence; Major Transaction. The Company or Allora, as applicable,
  has effected a Major Transaction without paying the Major Transaction Redemption
  Price to the Holder pursuant to Section 10(d) or, if the Holder did not elect
  a Redemption Upon Major Transaction, the Company has failed to meet the Assumption
  Requirements of Section 10(b) prior to effecting a Major Transaction.

                         (vi)
Failure to Adjust Exercise Price; Failure to Comply With Dispute
Resolution Procedures. The Company or Allora, as applicable, shall have
failed to comply in good faith with the Dispute Resolution Procedures (as
defined herein) or shall have failed to adjust the Exercise Price as required
under Section 5(e) following a Dilutive Issuance, or otherwise (after any
applicable Dispute Resolution Procedure required herein), and such failure
continues for ten (10) Business Days after the Holder provides written notice to
the Company or Allora, as applicable, that such performance by the Company is
past due. 

                         (vii)
Asset Purchase Failure. Failure of the Company, Allora, Epod Solar
(Wales) Limited and EPOD Industries, Inc. to either (a) enter into a fully
executed Asset Purchase Agreement (as defined in the Purchase Agreement), or (b)
consummate and close the Asset Purchase (as defined in the Purchase Agreement)
within forty-five (45) days of the date of issuance of this Warrant. 

                    (b)
  Mandatory Redemption; Certain Adjustments on Default.

                         (i)
Mandatory Redemption Amount. If any Event of Default shall occur then,
upon the occurrence and during the continuation of any Event of Default, (i) the
Company or Allora, as applicable, shall, immediately following the occurrence of
such Event of Default, provide notice of such Event of Default to the Holder, or
(ii) the Holder may, at its sole discretion and without any obligation to do so,
provide the Company or Allora, as applicable, with a notice of an Event of
Default (each, a “Default Notice”). Failure by the Company or Allora, as
applicable, to provide the Default Notice to the Holder within ten (10) Business
Days following the occurrence of an Event of Default shall result, at the option
of the Holder, in this Warrant becoming immediately redeemed by the Company or
Allora, as applicable (a “Mandatory Redemption”). Following a Mandatory
Redemption, the Company or Allora, as applicable, shall immediately pay to the
Holder in cash in U.S. dollars, in full satisfaction of its obligations
hereunder, an amount (such amount referred to herein as the “Default
Amount” or the “Mandatory Redemption Amount”) equal to the greater of
(i) and (ii) immediately below: 

(i) An amount equal to 100% of the
greater of (i) the Black-Scholes value of the remaining unexercised portion of
this Warrant on the date of such Default Notice, and (2) the Black-Scholes value
of the remaining unexercised portion of this Warrant on the Business Day
immediately preceding the date that the Mandatory
Redemption Amount is paid to the Holder (the “Default Exercise
Sum”); and

23

(ii) the Exercise Value of the Default
Exercise Sum to be prepaid, where “Exercise Value” means:

          (x)     
the Default Exercise Sum divided by the Exercise Price in effect on the date
that the Company or Allora, as applicable, pays the Default Amount;

MULTIPLIED BY

          (y)      the
greater of (i) the Market Price (as defined in the Debentures) for the EPOD
Stock or Allora Stock, as applicable, on the Default Notice Date, or (ii) the
Market Price on the date that the Company or Allora, as applicable, pays the
Default Amount.

                         Notwithstanding
the occurrence of an Event of Default, liquidated damages and any other Failure
Payments shall continue to accrue. Ten (10) Business Days after the occurrence
of an Event of Default (the “Default Amount Due Date”), the Default
Amount, together with all other amounts payable hereunder, shall immediately
become due and payable, all without demand, presentment or notice, all of which
hereby are expressly waived, together with all costs, including, without
limitation, legal fees and expenses, of collection, and the Holder shall be
entitled to exercise all other rights and remedies available at law or in
equity. If the Company or Allora, as applicable, fails to pay the Default Amount
by the Default Amount Due Date, (i) the Exercise Price shall be permanently
decreased (but not increased) (each, a “Default Adjustment”) on the first
Business Day of each calendar month thereafter (each a “Default Adjustment
Date”) until the Default Amount is paid in full, to a price equal to the
lesser of (x) 75% of the Exercise Price in effect on the first such Default
Adjustment Date, or (y) the lowest Market Price that has occurred on any Default
Adjustment Date since the date that the Event of Default began, and (ii) at any
time thereafter, the Holder shall have the right at any time, and from time to
time, so long as the Company or Allora, as applicable, remains in default (and
so long and to the extent that there are sufficient authorized shares), to
require the Company or Allora, as applicable, upon written notice (“Default
Exercise Notice”) (which may be given one or more times, from time to time
anytime after the Default Amount Due Date), to immediately issue (a “Default
Exercise”), in lieu of all or any specified portion (the “Specified
Portion”) of the unpaid portion (the “Unpaid Portion”) of the Default
Amount, a number (the “Default Share Amount”) of shares of EPOD Stock or
Allora Stock, as applicable, (subject, with respect to shares of Allora Stock,
to the Beneficial Ownership Limitation then in effect), equal to the Specified
Portion of the Default Amount divided by the Exercise Price in effect on
the date such shares are issued to the Holder (the “Default Shares”);
provided, that the Holder may require that such payment of shares be made in one
or more installments at such time and in such amounts as Holder chooses. The
Default Shares are due within five (5) Business Days of the date that the Holder
delivers a Default Exercise Notice to the Company or Allora, as applicable (the
“Default Share Delivery Deadline”). The Company and Allora, respectively,
shall take all such reasonable steps, obtain all such approvals and execute and
file all such documents as may be necessary to increase the number of shares which the Company
or Allora, as applicable, is authorized to issue the maximum number of Default
Shares that the Company may be required to issue upon Exercise of this Warrant
under this Section 11(b).

24

          If
the Company or Allora, as applicable, is unable to redeem all of the Warrants
submitted for redemption, it shall redeem a pro rata amount from each Holder
based on the number of Warrants submitted for redemption by such Holder relative
to the total number of Warrants submitted for redemption by all Holders.

          The
Holder shall not be entitled to receive Default Shares on a given date if and to
the extent that such issuance, if comprised of shares of Allora Stock, would
cause the Beneficial Ownership Limitation then in effect to be exceeded. If and
to the extent that the issuance of Default Shares comprised of shares of Allora
Stock with respect to a given Specified Portion would result in the a violation
of the Beneficial Ownership Limitation, then that particular Specified Portion
shall be automatically reduced to a value that would cause the number of Default
Shares to be issued to equal the Maximum Percentage, and the amount of such
reduction shall be added back to the Unpaid Portion of the Default Amount. 

          Upon
  the payment in full of the Mandatory Redemption Amount, the Holder shall promptly
  surrender this Warrant to or as directed by the Company or Allora, as applicable
  (or, if applicable, shall submit a signed notice that such Warrant has been
  lost, stolen or destroyed). Such redemption may be rescinded by Holder at any
  time prior to payment hereunder and the Holder shall have all rights as a holder
  of this Warrant until such time, if any, as the Holder receives full payment
  pursuant to this Section 11. No such rescission shall affect any subsequent
  Event of Default or impair any right consequent thereon.

                         
(ii) Liquidated Damages. The parties hereto acknowledge and agree that
the sums payable as liquidated damages or pursuant to a Mandatory Redemption
shall give rise to liquidated damages and not penalties. The parties further
acknowledge that (i) the amount of loss or damages likely to be incurred by the
Holder is incapable or is difficult to precisely estimate, (ii) the amounts
specified bear a reasonable proportion and are not plainly or grossly
disproportionate to the probable loss likely to be incurred by the Investor, and
(iii) the parties are sophisticated business parties and have been represented
by sophisticated and able legal and financial counsel and negotiated this
Agreement at arm’s length. 

          The
Default Amount, together with all other amounts payable hereunder, shall
immediately become due and payable, all without demand, presentment or notice,
all of which hereby are expressly waived, together with all costs, including,
without limitation, legal fees and expenses, of collection, and the Holder shall
be entitled to Exercise all other rights and remedies available at law or in
equity.

                    (c)
Redemption by Other Holders. Upon the Company’s or Allora’s, as applicable,
receipt of notice from any of the holders of the other Warrants (issued pursuant
to Section 1.07 of the Purchase Agreement) for redemption or repayment as a
result of an event or occurrence of an Event of Default or a Major Transaction
(each, an "Other Redemption Notice"), it shall immediately, but no later
than one (1) Business Day of its receipt thereof, forward to the Holder by facsimile a copy of
such notice. If the Company or Allora, as applicable, receives a Redemption
Notice and one or more Other Redemption Notices, during the seven (7) Business
Day period beginning on and including the date which is three (3) Business Days
prior to the Company’s or Allora’s receipt, as applicable, of the Holder’s
Redemption Notice and ending on and including the date which is three (3)
Business Days after the Company’s or Allora’s receipt, as applicable, of the
Holder's Redemption Notice and the Company or Allora, as applicable, is unable
to redeem all amounts designated in such Redemption Notice and such Other
Redemption Notices received during such seven (7) Business Day period, then the
Company or Allora, as applicable, shall redeem a pro rata amount from each
holder of the Warrants (including the Holder) based on the number of Warrants
submitted for redemption pursuant to such Redemption Notice and such Other
Redemption Notices received by the Company or Allora, as applicable, during such
seven (7) Business Day period. 

25

                    (d)
Injunction and Posting of Bond. In the event that the Event of
Default pertains to Allora’s failure to deliver unlegended shares of Allora
Stock to the Holder pursuant to an Exercise of this Warrant, Debenture
Conversion, legend removal request, or otherwise, Allora may not refuse such
unlegended share delivery based on any claim that such Holder or any one
associated or affiliated with such Holder has been engaged in any violation of
law.

                    (e)
Remedies, Other Obligations, Breaches and Injunctive Relief. The remedies
provided in this Warrant shall be cumulative and in addition to all other
remedies available under this Warrant and the other Transaction Documents, at
law or in equity (including a decree of specific performance and/or other
injunctive relief), and nothing herein shall limit the right of the Holder to
pursue actual damages for any failure by the Company to comply with the terms of
this Warrant. The Company or Allora, as and to the extent applicable,
acknowledges that a breach by it of its obligations hereunder could cause
irreparable harm to the Holder and that the remedy at law for any such breach
may be inadequate. The Company or Allora, as and to the extent applicable,
therefore agrees that, in the event of any such breach or threatened breach, the
Holder of this Warrant could seek, in addition to all other available remedies,
an injunction restraining any breach.

          12.     
Holder’s Redemptions.

                    (a)
Mechanics of Holder’s Redemptions. In the event that the Holder has sent a
Major Transaction Redemption Notice to the Company or Allora, as applicable,
pursuant to Section 10(d) or sends or receives a Default Notice pursuant to
Section 11(b)(i), respectively (each, a “Redemption Notice”), the Holder
shall promptly submit this Warrant to the Company or Allora, as applicable (if
delivery of the original Warrant is required pursuant to Section 2(l), upon
receipt of the full amount being redeemed. In the event of a redemption of less
than all of the outstanding portion of this Warrant, the Company or Allora, as
applicable, shall promptly cause to be issued and delivered to the Holder a new
Warrant representing the outstanding number of underlying Exercise Shares which
have not been redeemed and upon receipt of the full amount being redeemed and
such new Warrant in a form acceptable to the Holder, the Holder will exchange
this Warrant for such new Warrant. In the event that the Company or Allora, as
applicable, does not pay the applicable Redemption Price to the Holder within
the time period required, at any time thereafter and until the Company or
Allora, as applicable, pays such unpaid Redemption Price in full, the Holder
shall have the option, in lieu of redemption, to require the Company or Allora,
as applicable, to promptly return to the Holder all or any portion of this
Warrant that was submitted for redemption and for which the applicable Major
Transaction Redemption Price (together with any late charges thereon) has not
been paid. Upon the Company’s or Allora’s receipt, as applicable, of such
notice, (x) the applicable Redemption Notice shall be null and void with respect
to such Redemption Share Amount, (y) the Company or Allora, as applicable, shall
immediately return this Warrant, or issue a new Warrant to the Holder
representing the portion of this Warrant that was submitted for redemption. The
Holder’s delivery of a notice voiding a Redemption Notice and exercise of its
rights following such notice shall not affect the Company’s or Allora’s
obligations, as and to the extent applicable, to make any payments of Failure
Payments which have accrued prior to the date of such notice with respect to the
Warrant subject to such notice. 

26

                    (b)
Warrants Detachable. The Warrants constitute a separate, detachable security
from the Debentures. In the event of any redemption of the Debentures, in whole
or in part, by the Company or Allora, as applicable, the Holder shall retain its
outstanding Warrants. 

          13.     
Remedies, Other Obligations, Breaches and Injunctive Relief. The remedies
provided in this Warrant shall be cumulative and in addition to all other
remedies available under this Warrant and the other Transaction Documents, at
law or in equity (including a decree of specific performance and/or other
injunctive relief), and nothing herein shall limit the right of the Holder right
to pursue actual damages for any failure by the Company or Allora, as and to the
extent applicable, to comply with the terms of this Warrant. The Company or
Allora, as and to the extent applicable, acknowledges that a breach by it of its
obligations hereunder could cause irreparable harm to the Holder and that the
remedy at law for any such breach may be inadequate. The Company or Allora, as
and to the extent applicable, therefore agrees that, in the event of any such
breach or threatened breach, the holder of this Warrant could seek, in addition
to all other available remedies, an injunction restraining any breach. 

          14.      Dispute
Resolution. In the case of a dispute as to the determination of the Exercise
Price or the arithmetic calculation of the number of Exercise Shares issuable
upon any Exercise of this Warrant, the Company or Allora, as applicable, shall
promptly issue to the Holder the number of Exercise Shares that are not disputed
and resolve such dispute in accordance with this subsection. In the case of a
dispute as to the determination of the closing price or the Volume Weighted
Average Price of the Company’s or Allora’s common stock, as applicable, or the
arithmetic calculation of the Exercise Price, Market Price or any Redemption
Price, or the determination of whether or not a Dilutive Issuance has occurred,
the Company or Allora, as applicable, shall submit the disputed determinations
or arithmetic calculations via facsimile within two (2) Business Days of
receipt, or deemed receipt, of the Notice of Exercise or Redemption Notice or
other event giving rise to such dispute, as the case may be, to the Holder. If
the Holder and the Company or Allora, as applicable, are unable to agree upon
such determination or calculation within two (2) Business Days of such disputed
determination or arithmetic calculation being submitted to the Holder, then the
Company or Allora, as applicable, shall, within two (2) Business Days submit via facsimile (i) the
disputed determination of the closing price or the Volume Weighted Average Price
of the Company’s or Allora’s common stock, as applicable, to an independent,
reputable investment bank selected by the Company or Allora, as applicable, and
approved by the Holder, which approval shall not be unreasonably withheld, (ii)
the disputed arithmetic calculation of the Exercise Price, Market Price or any
Redemption Price to the Company’s or Allora’s independent, outside accountant,
as applicable, or (iii) the disputed facts regarding the occurrence of a
Dilutive Issuance (or any other matter referred to above that is not expressly
designated to the independent investment bank or the independent outside
accountant pursuant to (i) or (ii) immediately above) to an expert attorney from
a nationally recognized outside law firm (having at least 100 attorneys and
having with no prior relationship with the Company or Allora, as applicable)
selected by the Company or Allora, as applicable, and approved by the Holder.
The Company or Allora, as applicable, at its expense, shall cause the investment
bank or the accountant, law firm, or other expert, as the case may be, to
perform the determinations or calculations and notify the Company or Allora, as
applicable, and the Holder of the results no later than five (5) Business Days
from the time it receives the disputed determinations or calculations. Such
investment bank’s or accountant’s determination or calculation, as the case may
be, shall be binding upon all parties absent demonstrable error (collectively,
the “Dispute Resolution Procedures”).

27

          15.      Benefits
of this Warrant. 

          Nothing
in this Warrant shall be construed to confer upon any person other than the
Company or Allora, and Holder any legal or equitable right, remedy or claim
under this Warrant and this Warrant shall be for the sole and exclusive benefit
of the Company or Allora and Holder. 

          16.      Governing
Law.

          All
questions concerning the construction, validity, enforcement and interpretation
of this Agreement shall be governed by and construed and enforced in accordance
with the internal laws of the State of Delaware, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal
proceedings concerning the interpretations, enforcement and defense of the
transactions contemplated by this Agreement (whether brought against a party
hereto or its respective affiliates, directors, officers, shareholders,
employees or agents) shall be commenced exclusively in the state and federal
courts sitting in the State of Delaware. Each party hereby irrevocably submits
to the exclusive jurisdiction of the state and federal courts sitting in the
State of Delaware for the adjudication of any dispute hereunder or in connection
herewith or with any transaction contemplated hereby or discussed herein
(including with respect to the enforcement of any of the Transaction Documents),
and hereby irrevocably waives, and agrees not to assert in any suit, action or
proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is improper or is an
inconvenient venue for such proceeding. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such
suit, action or proceeding by mailing a copy thereof via registered or certified
mail or overnight delivery (with evidence of delivery) to such party at the
address in effect for notices to it under this Agreement and agrees that such
service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in
any way any right to serve process in any other manner permitted by law. The
parties hereby waive all rights to a trial by jury. If either party shall
commence an action or proceeding to enforce any provisions of this Agreement,
then the prevailing party in such action or proceeding shall be reimbursed by
the other party for its reasonable attorneys’ fees and other costs and expenses
incurred with the investigation, preparation and prosecution of such action or
proceeding.

28

          17.      Loss
of Warrant. 

          Upon
receipt by the Company or Allora, as applicable, of evidence of the loss, theft,
destruction or mutilation of this Warrant, and (in the case of loss, theft or
destruction) of indemnity or security reasonably satisfactory to the Company or
Allora, as applicable, and upon surrender and cancellation of this Warrant, if
mutilated, the Company or Allora, as applicable, shall execute and deliver a new
Warrant of like tenor and date. 

          18.     
Notice or Demands. 

          All
notices and other communications given or made pursuant to this Warrant shall be
in writing and shall be deemed effectively given: (a) upon personal delivery to
the party to be notified, (b) when sent by confirmed electronic mail or
facsimile if sent during normal business hours of the recipient, and if not so
confirmed, then on the next business day, (c) five (5) days after having been
sent by registered or certified mail, return receipt requested, postage prepaid,
or (d) one (1) Business Day after deposit with a nationally recognized overnight
courier, specifying next business day delivery, with written verification of
receipt. All communications shall be sent to the respective parties at their
address as set forth in the first paragraph of this Warrant, or to such email
address, facsimile number or address as subsequently modified by written notice
given in accordance with this Section 18. If notice is given to the Company or
Allora, a copy shall also be given to Burns & Levinson LLP, 125 Summer
Street, Boston, MA 02110, Attention: Andrew J. Merken, Esq. If notice is given
to the Holder, a copy shall also be given to Ellenoff Grossman & Schole LLP,
150 East 42nd Street, 11th Floor, New York, New York 10017, Attention: Stuart
Neuhauser, Esq. 

          19.      Amendment.

          This
Warrant may be modified or amended or the provisions hereof waived with the
written consent of the Company, Allora and the Required Warrant Holders. 

          20.      Purchase
Agreement.

          By
its acceptance of the Warrant, the Holder agrees to be bound by the applicable
terms of the Purchase Agreement. 

          21.     
Construction; Headings.

          This
Warrant shall be deemed to be jointly drafted by the Company, Allora, and the
Holder and shall not be construed against any person as the drafter hereof. The
headings of this Warrant are for convenience of reference and shall not
form part of, or affect the interpretation of, this Warrant. 

29

          22.      Nonwaiver
and Expenses.

          No
course of dealing or any delay or failure to exercise any right hereunder on the
part of Holder shall operate as a waiver of such right or otherwise prejudice
Holder’s rights, powers or remedies, If the Company or Allora, as applicable,
willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company or Allora, as
applicable, shall pay to Holder such amounts as shall be sufficient to cover any
costs and expenses including, but not limited to, reasonable attorneys’ fees,
including those of appellate proceedings, incurred by Holder in collecting any
amounts due pursuant hereto or in otherwise enforcing any of its rights, powers
or remedies hereunder. 

          23.      Limitation
of Liability.

          No
provision hereof, in the absence of any affirmative action by Holder to exercise
this Warrant to purchase Exercise Shares, and no enumeration herein of the
rights or privileges of Holder, shall give rise to any liability of Holder for
the purchase price of any EPOD Stock or Allora Stock, as applicable, or as a
stockholder of the Company, whether such liability is asserted by the Company or
by creditors of the Company. 

          24.     
Successors and Assigns.

          Subject
to applicable securities laws, this Warrant and the rights and obligations
evidenced hereby shall inure to the benefit of and be binding upon the
successors and permitted assigns of the Company and Allora, as applicable, and
the successors and permitted assigns of Holder. The provisions of this Warrant
are intended to be for the benefit of any Holder from time to time of this
Warrant and shall be enforceable by the Holder or holder of Exercise Shares.

          25.     
Severability.

          Wherever
possible, each provision of this Warrant shall be interpreted in such manner as
to be effective and valid under applicable law, but if any provision of this
Warrant shall be prohibited by or invalid under applicable law, such provision
shall be ineffective to the extent of such prohibition or invalidity, without
invalidating the remainder of such provisions or the remaining provisions of
this Warrant. 

(Signature page follows.)

30

          IN
WITNESS WHEREOF, the Company has caused this Warrant to be signed in its name by
its duly authorized officer as of the Date of Issuance set forth herein. 

	 	COMPANY: 
	 	  	  
	 	EPOD Solar Inc. 
	 	  	  
	 	/s/ Michael Matvieshen 
	 	By: 	Michael Matvieshen 
	 	Its: 	Chief Executive Officer
  

LIMITED JOINDER SOLELY FOR THE PURPOSES SET FORTH BELOW:

          The
undersigned hereby executes this Warrant, as of the Date of Issuance set forth
herein, solely with respect to its obligations set forth herein. 

	 	ALLORA: 
	 	  	  
	 	Allora Minerals, Inc.
    
	 	  	  
	 	/s/ Michael Matvieshen 
	 	By: 	 Michael Matvieshen 
	 	Its: 	President and Chief Executive
  
	 	  	Officer 

31

EXHIBIT A 

NOTICE OF EXERCISE FORM FOR WARRANT 

TO: [____________________] 

       The undersigned hereby
irrevocably Exercises the right to purchase ____________ of the shares of Common
Stock (the “Common Stock”) of [_______________], a [___________]
corporation (the “Company”), evidenced by the attached warrant (the
“Warrant”), and herewith makes payment of the Exercise price with respect
to such shares in full, all in accordance with the conditions and provisions of
said Warrant. 

1. The undersigned agrees not to offer, sell, transfer or
otherwise dispose of any of the Common Stock obtained on Exercise of the
Warrant, except in accordance with the provisions of Section 8(a) of the
Warrant. 

2. The undersigned requests that stock certificates for such
shares be issued free of any restrictive legend, if appropriate, and a warrant
representing any unexercised portion hereof be issued, pursuant to the Warrant
in the name of the undersigned and delivered to the undersigned at the address
set forth below: 

Dated:________

	 
	Signature 
	 
	 
	 
	Print Name 
	 
	 
	 
	Address 

	 
	NOTICE 
	 
	
      The signature to the foregoing Notice of Exercise Form
      must correspond to the name as written upon the face of the attached
      Warrant in every particular, without alteration or enlargement or any
      change whatsoever. 

	 

32

EXHIBIT B 

ASSIGNMENT 

(To be executed by the registered holder 
desiring to
transfer the Warrant) 

FOR VALUE RECEIVED, the undersigned holder of the attached
warrant (the “Warrant”) hereby sells, assigns and transfers unto the
person or persons below named the right to purchase _______ shares of the Common
Stock of [_____________], a [_________] corporation, evidenced by the
attached Warrant and does hereby irrevocably constitute and appoint
_______________________ attorney to transfer the said Warrant on the books of
the Company, with full power of substitution in the premises. 

	Dated:   ______________	
	 	Signature 

Fill in for new registration of Warrant: 

	 	 
	Name 	 
	 	 
	 	 
	Address 	 
	 	 
	 	 
	Please print name and address of assignee (including zip
      code number) 	 

	 
	NOTICE 
	 
	
      The signature to the foregoing Assignment must correspond
      to the name as written upon the face of the attached Warrant in every
      particular, without alteration or enlargement or any change whatsoever.
      

	 

33Allora Minerals, Inc.: Exhibit 10.1 - Prepared by TNT Filings Inc.

Exhibit 10.1 

ASSET AND STOCK PURCHASE AGREEMENT 

          This
ASSET AND STOCK PURCHASE AGREEMENT (the “Agreement”), is made as of this
30th day of June, 2009, by and among EPOD Solar Inc., a corporation
organized under the laws of the province of British Columbia, Canada (the
“Parent”), Epod Solar (Wales) Limited, a corporation organized under the
Companies Act 1985 (Company Registration Number 04645882) (“Epod UK”),
EPOD Industries Inc., a corporation organized under the laws of British Columbia
(“Epod Industries”), and Allora Minerals Inc., a Nevada corporation (the
“Buyer”).

W I T N E S S E T H : 

          WHEREAS,
each of Epod UK and Epod Europe (as defined below) is a wholly-owned subsidiary
of Parent; 

          WHEREAS,
Great Lakes (as defined below) is a wholly-owned subsidiary of Epod Industries;

          WHEREAS,
Sellers are engaged in the development, sale, marketing and support of solar
energy products for commercial and industrial applications;

          WHEREAS,
Buyer wishes to purchase or acquire from Epod UK and Epod UK wishes to sell,
assign and transfer to Buyer, all of the assets and properties of Epod UK held
in connection with, necessary for or material to the Business;

          WHEREAS,
Buyer acknowledges that the assets and properties of Epod UK are subject to a
first fixed charge in favor of Parent Investor which shall be assumed by Buyer
on or immediately prior to the Closing. 

          WHEREAS,
Buyer has agreed to assume the Assumed Liabilities (as that term is defined
herein) of Epod UK and certain Liabilities of the Parent; and 

          WHEREAS,
Buyer wishes to purchase or acquire from Parent and EPOD Industries, as
applicable, (a) all of the issued and outstanding shares of capital stock of
Epod Solar Europe Ltd, a corporation organized under the laws of the Republic of
Ireland (“Epod Europe”), held by Parent as of the date hereof, and (b)
all of the issued and outstanding shares of capital stock of and Great Lakes
Solar Utilities Inc., a corporation organized under the laws of the province of
Ontario, Canada (“Great Lakes”) held by Epod Industries (Great Lakes and,
together with Epod UK and Epod Europe, a “Seller Subsidiary”, and
together with the Parent and Epod Industries, the “Sellers”), which
shares represent all of the issued and outstanding capital stock of Great Lakes
and Epod Europe, respectively, all for the consideration and upon the terms and
subject to the conditions hereinafter set forth. 

          NOW,
THEREFORE, the parties hereto, in consideration of the mutual promises and other
consideration set forth below, the receipt and adequacy of which hereby is
acknowledged, and intending to be legally bound hereby, do represent, warrant,
covenant and agree as follows: 

SECTION 1 
DEFINITIONS 

          1.01.      “Accounts
Receivable” shall have the meaning set forth in Section 2.01(g) . 

          1.02.     
“Acquired Assets” shall have the meaning set forth in Section 2.01. 

          1.03.     
“Affiliate” means, as applied to any Person, any other Person directly or
indirectly controlling, controlled by, or under common control with that Person.
For the purposes of this definition, “control” (including with correlative
meanings, the terms “controlling”, “controlled by” and “under common control
with”) as applied to any Person, means the possession, directly or indirectly,
of the power to direct or cause the direction of the management and policies of
that Person, whether through ownership of voting securities or by contract or
otherwise. 

          1.04.      “Assumed
Contracts” shall have the meaning set forth in Section 2.01(b) . 

          1.05.     
“Assumed Liabilities” shall have the meaning set forth in Section 5.02.

          1.06.     
“Business” shall include research, development, marketing and sales of
the Products of Epod UK, and of services related to the Products, as conducted
by the Epod UK prior to the Closing. 

          1.07.     
“Business Records” shall have the meaning set forth in Section 2.01(d) .

          1.08.     
“Buyer” shall have the meaning set forth in the preamble. 

          1.09.     
“Buyer Indemnified Parties” shall have the meaning set forth in Section
8.02(a) . 

          1.10.      “Claim”
shall mean any and all administrative or judicial actions, suits, arbitrations,
orders, claims, Liens, notices, notices of violations, investigations,
complaints, requests for information, proceedings, or other communication
(written or oral), whether criminal or civil. 

          1.11.      “Closing”
and “Closing Date” shall have the respective meanings assigned to them in
Section 5.01 hereof. 

          1.12.     
“Contract” means any agreement, obligation, undertaking, lease, evidence
of Indebtedness, mortgage, indenture, security agreement or other contract
(whether written or oral and whether expressed or implied). 

          1.13.     
“Environmental Law” means all federal, state, local and foreign
environmental, health and safety Laws, common law orders, decrees, judgments,
codes and ordinances and all rules and regulations promulgated thereunder, civil
or criminal, including, without limitation, Laws relating to emissions,
discharges, releases or threatened releases of Hazardous Material, pollutants,
contaminants, chemicals, or industrial, toxic or hazardous substances or wastes
into the environment or otherwise relating to the manufacture, processing,
distribution, use, treatment, storage, disposal, transport or handling of
Hazardous Material, pollutants, contaminants, chemicals, or industrial, solid,
toxic or hazardous substances or wastes. 

          1.14.      “Excluded
Assets” shall have the meaning set forth in Section 2.02. 

          1.15.      “Excluded
Liabilities” shall have the meaning set forth in Section 4.03. 

          1.16.     
“Fixed Assets” shall have the meaning set forth in Section 2.01(a) . 

          1.17.      “General
Intangibles” shall have the meaning set forth in Section 2.01(c) . 

          1.18.     
“Governmental or Regulatory Authority” means any court, tribunal,
arbitrator, authority, agency, commission, official or other instrumentality of
the United States and Canada, any foreign country or any domestic or foreign
state, county, city or other political subdivision, and shall include, without
limitation, the Securities and Exchange Commission, and the various federal,
state and foreign securities regulators and taxation authorities. 

          1.19.      “Hazardous
Material” means (i) any petroleum or petroleum products, radioactive
materials, asbestos in any form that is or could become friable, urea
formaldehyde foam insulation and transformers or other equipment that contain
dielectric fluid containing levels of polychlorinated biphenyls (PCBs); (ii) any
chemicals, materials, substances or wastes which are now defined as or included
in the definition of “hazardous substances”, “hazardous wastes,” “hazardous
materials,” “extremely hazardous wastes,” “restricted hazardous wastes,” “toxic
substances,” “toxic pollutants” or words of similar import, under any
Environmental Law; and (iii) any other chemical, material, substance or waste,
exposure to which is now prohibited, limited or regulated by any Governmental or
Regulatory Authority. 

          1.20.     
“Indebtedness” of any Person means all obligations of such Person (i) for
borrowed money, (ii) evidenced by notes, bonds, debentures or similar
instruments, (iii) for the deferred purchase price of goods or services (other
than trade payables or accruals incurred in the ordinary course of the
Business), (iv) under capital leases and (v) in the nature of guarantees of the
obligations described in clauses (i) through (iv) above of any other Person.

          1.21.      “Indemnified
Party” shall have the meaning set forth in Section 8.02(c) . 

          1.22.     
“Indemnifying Party” shall have the meaning set forth in Section 8.02(c)
.. 

          1.23.     
“Intellectual Property” shall mean any or all of the following, and all
rights, and all title and interest therein or associated therewith: (a) United
States, Canadian, German, United Kingdom and foreign patents and applications
therefor and all reissues, divisions, renewals, extensions, provisionals,
continuations and continuations-in-part thereof; (b) inventions (whether or not
patentable), invention disclosures, invention improvements, trade secrets,
computer software programs (in both source code and object code form),
technology, technical data and customer lists (including contact information for
such customers), tangible or intangible proprietary information, and all
documentation relating to any of the foregoing; (c) copyrights, copyrights
registrations and applications therefor, and all other rights corresponding
thereto throughout the world; (d) industrial designs and any registrations and
applications therefor owned by a Selling Subsidiary; (e) trade names, including,
without limitation, registered trademarks and common law trademarks and service
marks, logos, trademark and service mark registrations and applications therefor
throughout the world; (f) all databases and data collections and all rights
therein throughout the world; (g) moral and economic rights specifically
designated for authors or inventors, however denominated, throughout the world; and (h)
any similar or equivalent rights to any of the foregoing anywhere in the world. 

          1.24.     
“Knowledge” means the actual knowledge of a Person with respect to any
fact, event or condition, as well as the knowledge that such party reasonably
would be expected to have acquired in the ordinary course of business and the
prudent management of its own affairs. Such definition shall include any form of
such term, such as knows, known, etc., whether or not capitalized, as used in
this Agreement with respect to a party’s awareness of the presence or absence of
a fact, event or condition. 

          1.25.     
“Laws” means all laws, statutes, rules, regulations, ordinances and other
pronouncements having the effect of law in Canada, the United States, any
foreign country or any domestic or foreign state, province, county, city or
other political subdivision or of any Governmental or Regulatory Authority. 

          1.26.     
“Liability” or “Liabilities” means all Indebtedness, obligations
and other liabilities (or contingencies that have not yet become liabilities) of
a Person (whether absolute, accrued, contingent (or based upon any contingency),
fixed or otherwise, or whether due or to become due). 

          1.27.      “License”
means any license, permit, certificate of authority, authorization, approvals,
registration, franchise and similar consent granted or issued by any
Governmental or Regulatory Authority. 

          1.28.     
“Liens” means claims, pledges, security interests, mortgages, conditional
sales agreement, liens, charges, restrictions, consignments or conditional sales
agreements, or other encumbrances of whatever nature, whether created by
statute, Contract, process of law or otherwise, and whether or not recorded or
otherwise perfected. 

          1.29.     
“Loss” means any and all damages, fines, fees, penalties, deficiencies,
diminution in value of investment, losses and expenses, including without
limitation, interest, reasonable expenses of investigation, court costs,
reasonable fees and expenses of attorneys, accountants and other experts or
other expenses of litigation or other proceedings or of any claim, default or
assessment (such fees and expenses to include without limitation, all fees and
expenses, including, without limitation, fees and expenses of attorneys, when
and as incurred in connection with (i) the investigation or defense of any Third
Party Claims, or (ii) asserting or disputing any rights under this Agreement
against any party hereto or otherwise).

          1.30.     
“Material Adverse Effect” means any change or effect of any event or
circumstance which, individually or when taken together with all other changes,
effects, events or circumstances, is or could reasonably be expected to be,
materially adverse to the assets, financial condition, business or results of
operation of a Person; excluding, however, any adverse effect due to changes,
after the date of this Agreement, in conditions affecting the economy generally
or the general market addressed by such Person’s products and/or services. 

          1.31.     
“Parent” shall have the meaning set forth in the preamble. 

          1.32.     
“Person” means any natural person, corporation, general or limited
partnership, limited liability company or partnership, proprietorship, other
business organization, estate, trust, union, association or Governmental or
Regulatory Authority. 

          1.33.     
“Products” shall mean all of each Selling Subsidiary’s proprietary
products and all intellectual property rights associated therewith and the
goodwill and business appurtenant thereto.

          1.34.     
“Purchase Price” shall have the meaning set forth in Section 3.01. 

          1.35.     
“Seller” and “Sellers” shall have the meanings set forth in the
seventh recital. 

          1.36.     
“Seller Indemnified Parties” shall have the meaning set forth in Section
8.02(b) . 

          1.37.     
“Seller Subsidiary” and “Seller Subsidiaries” shall have the
meanings set forth in the seventh recital. 

          1.38.     
“Tax” or “Taxes” means any and all federal, state, local or
foreign taxes, fees, levies, duties, tariffs, imposts and other governmental
charges of any nature (together with any interest, penalties and additions to
tax) including, without limitation, taxes or other charges on, or with respect
to, income, gross receipts, property, sales, use, capital or net worth. 

          1.39.     
“Tax Return” means any return, report or statement (including any
information return) required to be filed for purposes of a particular Tax. 

          1.40.     
“Third Party” shall mean any Person who is not a party to this Agreement,
nor is an Affiliate of any party to this Agreement.

          1.41.     
“Third Party Claim” shall mean a Claim asserted by a Third Party. 

SECTION 2 
PURCHASE AND SALE OF ASSETS OF EPOD UK 

          2.01.      Purchase
and Sale of Epod UK Assets. Upon the terms and subject to the conditions set
forth in this Agreement, and in reliance on the representations and warranties
contained herein, at the Closing, Epod UK shall sell, convey, transfer, assign
and deliver to Buyer (or Parent shall cause Epod UK to sell, convey, transfer
assign and deliver), and Buyer will purchase from Epod UK, for the consideration
hereinafter set forth, good and marketable title (save for the first fixed
charge referred to above) to all of the assets and properties of Epod UK set
forth below (collectively, the “Acquired Assets”): 

          (a)     
Those fixed assets of Epod UK used in or necessary for the Business (the
“Fixed Assets”), including without limitation the machinery and
equipment, testing devices, computer equipment (hardware, software, peripherals,
laptops, PDAs, etc.), furniture, fixtures, any tooling, office equipment,
signage, company owned vehicles and any other types of fixed assets including,
but not limited to, those items listed and described on Schedule 2.01(a)
hereto, which Schedule shall be revised by Parent or Epod UK as of the Closing
Date to correctly note any additions to and deletions from the Fixed Assets, if
any, which may have occurred between the date hereof and the Closing Date.

          (b)      All
of Epod UK’s right, title and interest in, to and under all Contracts listed on
Schedule 2.01(b) hereto, which shall include all Contracts of or
relating to the Business (including, without limitation, all agreements with
employees, consultants and sales representatives of each Selling Subsidiaries), Contracts, leases, licenses, works in process,
and proposals of Epod UK including, without limitation, any and all deposits or
prepayments thereunder, together with all necessary consents to assignment;
provided that with respect to the Contracts for work in process, said Contracts
shall be fully assignable to Buyer (the “Assumed Contracts”).

          (c)     
All Intellectual Property of Epod UK including, without limitation, those assets
set forth on Schedule 2.01(c) hereto, together with the goodwill and
business appurtenant thereto and any licenses and sublicenses granted and
obtained with respect thereto, rights thereunder, remedies against infringements
thereof, and rights to protection of interests therein under the applicable Laws
of all jurisdictions, customer lists, Epod UK’s existing telephone and facsimile
numbers, all rights in and to the trademarks and tradenames associated with any
Product, along with all choses in action, permits, Licenses, approvals,
variances and other intangible assets of the Business (in each case to the
extent transferable) and all goodwill of the Business (other than corporate
authorizations to transact the Business which are related to Epod UK as a legal
entity) (“General Intangibles”). 

          (d)     
All books, records, files, catalogues, Contracts, customer lists, prospect
lists, dealer and distributor lists, lists of open customer purchase orders and
sales leads, sales literature, sales records, engineering data, product design,
drawings and information, operating records, certain research results and test
records and other miscellaneous documentation that relate to the Acquired Assets
or to the Business, whether such materials and documents are in written or
electronic form (the “Business Records”). 

          (e)      All
of Epod UK’s inventory, raw materials, supplies, work in process, finished
goods, packaging and other manufacturing supplies of any nature relating to the
Business.

          (f)      All
of Epod UK’s right, title and interest in all real property owned or leased by
it at the facilities located in Wales, United Kingdom, including all structures
and improvements thereon and all interests therein used in the Business.

          (g)     
The Accounts Receivable of Epod UK set forth on Schedule 2.1(g)
hereto.

          (h)      All
of Epod UK’s right, title and interest as of the Closing Date in, to and under
all other assets of every kind and nature used or intended to be used in or
necessary to the operation of the Business, including, without limitation, any
other data wherever found or of whatever kind of Epod UK not described above
reasonably required to conduct the Business. 

          In
order to effect the foregoing, Epod UK shall execute and deliver to Buyer at the
Closing a Bill of Sale in the form attached as Exhibit A hereto. Except
as otherwise set forth or disclosed herein, all the Acquired Assets are, and at
the Closing Date will be, located at the facilities of Epod UK in Wales, United
Kingdom. 

          As
of the Closing Date, the Acquired Assets shall be transferred or otherwise
conveyed to Buyer free and clear of all Liabilities, obligations, Liens, Claims
(including Third Party Claims) and encumbrances excepting only Assumed
Liabilities as listed in Section 4.02. 

          2.02.     
Excluded Assets. The following assets of Epod UK (collectively, the
“Excluded Assets”) are not part of the sale and purchase contemplated
hereunder, are excluded from the Acquired Assets and Parent Shares and shall
remain the property of Seller after the Closing: 

          (a)      All
corporate minute books, records and seals of Epod UK. 

          (b)      All
personnel records and other records that a Epod UK is required by Law to retain
in its possession. 

          (c)      All
Claims for refund of Taxes and other governmental charges of whatever nature.
Epod UK agrees to provide Buyer with reasonable cooperation in connection with
any audit or assessment of Taxes, interest or other charges with respect to any
period prior to Closing. 

          (d)     
All rights of Epod UK under this Agreement and the other agreements to be
entered into in connection with the transactions contemplated hereby.

          (e)     
All agreements regarding the purchase and sale or governing the rights of, the
capital stock of Epod UK. 

          2.03.     
Assets of Parent, Epod Europe and Great Lakes. Except for certain
Contracts to which the Parent is a party as of the date hereof and that shall be
considered, for purposes hereof, as Assumed Contracts and are included on
Schedule 2.01(b) hereto, the right, title and interest in such Assumed
Contracts shall be assigned, transferred and conveyed to Buyer hereunder for the
consideration hereinafter set forth, and unless otherwise provided for herein,
no assets of the Parent will be purchased by Buyer. No assets of Epod Europe or
Great Lakes shall be purchased by Buyer. 

SECTION 3 
PURCHASE OF STOCK OF EPOD EUROPE AND GREAT LAKES

          Section
3.01.      Purchase of Shares of Epod Europe
and Great Lakes. At the Closing, each of the Parent and Epod Industries,
respectively, will sell, convey, transfer and deliver to Buyer, and Buyer will
purchase from Parent, for the consideration hereinafter set forth, 100 Common
shares of Great Lakes held by Epod Industries and 2 ordinary shares of Epod
Europe held by Parent as of the Closing Date, which represents all of the issued
and outstanding shares of capital stock of Great Lakes and Epod Europe
(collectively, the “Parent Shares”). All Parent Shares shall be
transferred or otherwise conveyed by the Parent to Buyer free and clear of all
Liabilities, obligations, Liens, Claims (including Third Party Claims). 

SECTION 4 
PURCHASE PRICE 

          4.01.      Amount
and Payment of the Purchase Price. In consideration for the Acquired Assets
and Parent Shares, Buyer shall issue to the Parent the aggregate amount of Two
Million Six Hundred Fifty-One Thousand (2,651,000) validly issued, fully paid
and non-assessable new shares of common stock, $0.001 par value per share (the
“Common Stock”), of the Buyer (the “Purchase Price”) on the
Closing Date. 

          4.02.     
Allocation of Purchase Price. The parties agree to allocate the Purchase
Price amongst the Acquired Assets and Parent Shares in a manner which causes the
least Liabilities for Taxes under applicable Law, and will collectively execute,
prepare, file (or cause to have prepared and filed) all applicable forms,
notices and filings as are required by applicable Law.

          4.03.     
Employees. The employees of each of Epod Europe and Great Lakes shall
remain employed by such Selling Subsidiary following the Closing Date, upon such
terms and conditions as are in effect immediately prior to the Closing Date. The employees
of Epod UK shall be employed by another subsidiary of Buyer formed for the
purpose of holding all the assets and liabilities of Epod UK, upon such terms
and conditions as are in effect immediately prior to Closing. Sellers hereby
jointly authorize Buyer to offer employment to their respective employees, waive
any rights they may have prohibiting such employees from being employed by
Buyer, and shall not offer employment to any employees who have accepted
employment with Buyer. Nothing in this Section 4.03 shall be deemed to be a
contract for the benefit of any employee. Sellers shall use their respective
best efforts to assist Buyer in obtaining the services of all current employees
of a Seller that Buyer wishes to so retain. 

SECTION 5
ASSUMPTION OF LIABILITIES OF EPOD UK 

          5.01.      Nonassumption
of Liabilities of Epod UK and Parent and Indemnification. Except for the
first charge in favor of Parent Investor referred to in the fifth recital of
this Agreement setting out the background and as specifically set forth in
Section 5.02, Buyer does not assume any Liabilities of Epod UK or Parent
whatsoever. Parent or Epod UK, as applicable, have paid or made arrangement for
payment of all other debts and Liabilities known to either of them and incurred
in connection with the transaction of the Business and due and payable prior to
the Closing Date. The parties intend that Buyer shall acquire ownership of the
Acquired Assets free and clear of all Liens and Third Party Claims (whether
private, governmental or otherwise) whatsoever, and each of Parent and Epod UK
represents and warrants that such sale shall be accomplished without expense or
Liability for any such Third Party Claims to Buyer. 

          5.02.      Assumed
Liabilities. Buyer shall assume the following Liabilities of Epod UK or
Parent, as applicable (collectively, the “Assumed Liabilities”): 

          (a)      The
purchase orders as of the Closing Date from Epod UK’s customers regarding the
Products, accepted in the ordinary course of the Business. 

          (b)      The
purchase orders of Epod UK as of the Closing Date to its suppliers regarding the
Business, so long as such purchase orders were accepted in the ordinary course
of the Business as conducted by Epod UK and contain pricing and other terms
which are usual and ordinary in the normal course of the Business.

          (c)      All
executory duties and obligations of Epod UK (and, as applicable, the Parent)
under all of the Assumed Contracts as provided in the Assignment and Assumption
of Contract Agreement attached hereto as Exhibit C. 

          (d)      The
outstanding balance of all of Epod UK’s trade debt Liabilities incurred prior to
the Closing Date in the ordinary course of the Business, as set forth on
Schedule 5.02(d) .

          (e)      All
warranties and service obligations arising after the Closing Date with respect
to any Products sold by Epod UK prior to the Closing Date. 

          (f)      All
accrued and unpaid property Taxes as of the Closing Date on the Acquired
Assets.

          (g)      All
sales and use Taxes due with respect to all Accounts Receivable included in the
Acquired Assets, and all other accrued and unpaid sales and use Taxes due as of
the Closing Date. 

          (h)      All
of Epod UK’s obligations under existing benefit plans arising on or after the
Closing Date. 

          (i)      The
warrants (the “Warrants”) issued to Dr. Chandra Pemmasani (the “Parent
Investor”) by the Parent which warrants shall, as of the Closing Date and
under their own terms, automatically be deemed warrants to purchase solely
shares of Common Stock of the Buyer. 

          (j)      The
secured convertible debentures (the “Debentures”) issued to the Parent
Investor by the Parent which Debentures shall, as of the Closing Date and under
their own terms, automatically be deemed to be convertible solely into shares of
Common Stock of the Buyer. 

          (k)      Those
certain (i) (A) debenture, and (B) guaranty and indemnity, between Epod UK and
the Parent Investor, and (ii) (A) Share Pledge Agreement, and (B) Non-Recourse
Guaranty, between Mr. Michael Matvieshen and the Parent Investor, evidencing the
security interest granted to the Parent Investor to secure the Parent’s
obligations under the Debentures. 

          (l)      The
warrants (the “Financial Advisor Warrants”) issued to Baneberry Capital
Corp. and CCI Financial Group Inc. by the Parent which Financial Advisor
Warrants shall, as of the Closing Date and under their own terms, automatically
be deemed warrants to purchase solely shares of Common Stock of the Buyer. 

          (m)     
Any Liabilities arising out of or in connection with any Indebtedness of Epod UK
for borrowed money. 

          5.03.      Excluded
Liabilities. Notwithstanding the foregoing, and except as expressly set
forth in this Agreement with respect to the Assumed Liabilities, Buyer shall not
assume or become liable for, and shall not, by execution or performance of this
Agreement, purchase of the Acquired Assets or otherwise, become responsible for,
be liable with respect to and otherwise be obligated to pay, perform, discharge
or guaranty any Liability or obligation of Epod UK or Parent (whether fixed,
absolute, contingent, known, unknown, direct, indirect or otherwise) arising
prior to the Closing Date, all of which Liabilities, debts and obligations Epod
UK agrees to promptly pay or discharge (or Parent agrees to cause to have paid
or discharged) including, without limitation, the following (the
“Excluded Liabilities”):

          (a)     
Any Liability or obligation of Epod UK or Parent for any federal, state,
provincial, local and foreign Taxes, assessments, and other governmental charges
payable or remittable by it or levied upon it or its properties, assets, income,
or franchises which are due and payable. 

          (b)      Any
Claims, acts, errors, omissions, Losses, costs or Liabilities with respect to
Epod UK, the Acquired Assets, Epod UK’s trade practices or the Business as
conducted by Epod UK arising or accruing or based on the operation of the
Business prior to the Closing Date or otherwise based on any acts or omissions
of Epod UK made at any time thereafter including, but not limited to, unpaid
salary, products liability, environmental, tort, antitrust, workers’
compensation liability, employment practices liability, unfair competition,
business practices liability and similar Claims. 

          (c)      Any
Liabilities arising out of, incurred in connection with or related to the
ownership of the Excluded Assets. 

          (d)     
Any Liabilities arising out of or in connection with any Indebtedness of the
Parent for borrowed money.

          (e)      Any
inter-company accounts payable.

          (f)      Except
as otherwise provided in Section 5.02 above, any Liabilities to employees or
former employees of Epod UK, to the extent that the event or state of facts
giving rise to such Liability occurred prior to the Closing Date. 

          (g)     
Any loans outstanding made by the Parent or other Indebtedness of the Parent as
of the date hereof to any Person. 

SECTION 6 
CLOSING 

          6.01.      Closing.
The closing of the purchase and sale of the Acquired Assets and Parent Shares
(the “Closing”) shall be held at the offices of Burns & Levinson LLP
in Boston, Massachusetts, remotely via the exchange of documents and signatures
or at such other time and place as the parties mutually may agree, on the first
day in which the conditions set forth in this Section 5 have been satisfied or
waived, but in any event no later than forty five (45) days from the Closing of
that certain Securities Purchase Agreement, dated as of the date hereof, among
the Parent, Buyer and the Purchasers named therein (the “Closing
Date”).

          6.02.     
Deliveries of Sellers. Each Seller, as applicable, shall deliver or cause
to be delivered to Buyer at the Closing: 

          (a)      A
Bill of Sale with warranty covenants of title, conveying good and marketable
title in the Acquired Assets to Buyer in accordance with this Agreement, free
and clear of all Liens, in substantially the form attached as Exhibit A
hereto, executed by such Seller. 

          (b)      Any
and all documents of title necessary to transfer ownership to the Buyer of the
Acquired Assets, duly executed by such Seller and any other parties thereto.

          (c)     
An Assignment of Intellectual Property in substantially the form attached as
Exhibit B hereto, executed by such Seller. 

          (d)      An
Assignment and Assumption of Contracts Agreement in substantially the form
attached as Exhibit C hereto, executed by such Seller. 

          (e)     
All documents necessary to transfer any other General Intangibles being
purchased by Buyer hereunder, executed by such Seller and any other parties.

          (f)      All
such other deeds, endorsements, assignments and other instruments as, in the
opinion of Buyer’s counsel, are necessary or desirable to vest in Buyer good,
valid and marketable title to and ownership of the Acquired Assets. 

          (g)     
A certified copy of resolutions, duly adopted by the Boards of Directors and
stockholders of each Seller, authorizing the transactions contemplated hereby.

          (h)     
Such certificates issued by the appropriate Governmental or Regulatory Authority
as required to evidence the legal existence and good standing of such Seller.

          (i)      The
Parent shall deliver or cause to be delivered to Buyer the following with
respect to the Parent Shares: (A) stock powers duly endorsed by the Parent or
Epod Industries, as applicable, and otherwise in form acceptable for transfer of
the Parent Shares on the books of the Epod Europe and Great Lakes, respectively,
to Buyer; (B) certificates representing the Parent Shares; and (C) any approvals
or consents required with respect to the transfer of the Parent Shares to Buyer.

          (j)      The
Lock Up Agreement dated as of the Closing Date, by the Holder (as defined
therein) and Buyer. 

          (k)     
Such other closing documents and instruments as Buyer reasonably may require.

          6.03.      Deliveries
of Buyer. Buyer shall deliver or cause to be delivered to Sellers at the
Closing:

          (a)      The
amount of Two Million Six Hundred Fifty-One Thousand (2,651,000) shares of
fully-paid, non-assessable shares of Common Stock, issued to the Parent in
accordance with Section 4.01; 

          (b)      An
Assignment of Intellectual Property in substantially the form attached as
Exhibit B hereto, executed by Buyer. 

          (c)     
An Assignment and Assumption of Contracts Agreement in substantially the form
attached as Exhibit C hereto, executed by Buyer. 

          (d)     
A certificate, executed by Buyer’s Secretary certifying the resolutions of
Buyer’s Board of Directors approving the transactions contemplated hereby. 

          (e)     
A certificate executed on behalf of Buyer by its President or a Vice President,
certifying as to Buyer’s satisfaction of the conditions set forth in Section
6.05(a) and (b). 

          (f)      An
executed first charge in the form reasonably required by Parent Investor over
the assets of Epod UK. 

          6.04.     
Conditions to the Buyer’s Obligations. The obligation of the Buyer to
consummate the transactions to be performed by it in connection with the Closing
will be subject to the satisfaction (or waiver by the Buyer, in whole or in
part, in writing; provided that any such waiver shall require the prior written
consent of the Parent Investor) of the following conditions as of the time of
the Closing: 

          (a)      Each
representation and warranty set forth in Section 7 will be true and correct in
all material respects at and as of the time of the Closing as though then made,
except for changes expressly required by this Agreement and except for any
representation or warranty that expressly relates to a specific prior date. 

          (b)      Each
Seller will have performed and complied in all material respects with all of the
covenants and agreements (considered collectively), and each of the covenants
and agreements (considered individually), required to be performed by such
Seller under this Agreement or any other agreements, documents and instruments
to be entered into by such Seller in connection with the transactions
contemplated hereby at or prior to the Closing. 

          (c)     
There shall be no proceeding commenced or threatened against the Buyer or any
Seller involving this Agreement or the transactions contemplated herein or any
judgment, decree, injunction or order which prohibits the consummation of the
transactions contemplated by this Agreement. 

          (d)     
Sellers shall have delivered the Acquired Assets and Parent Shares to the Buyer,
free and clear of all Liabilities, obligations, Liens, Claims (including Third
Party Claims, whether private, governmental or otherwise) and encumbrances,
excepting only Assumed Liabilities.

          (e)     
There shall have been no material adverse change in the condition (financial or
otherwise), results of operations, properties, assets, Liabilities of a Seller
or the Business. 

          (f)
The pro forma consolidated financial statements of the Buyer (including the
Acquired Assets) shall have been completed in accordance with the Exchange Act ,
and the rules and regulations promulgated thereunder, and the report of
independent auditors with respect to such financial statements completed and
submitted. 

          (g)      Sellers
shall have delivered to the Buyer the items set forth in Section 6.02. 

          6.05.     
Conditions to the Sellers’ Obligations. The obligation of Sellers to
consummate the transactions to be performed by it in connection with the Closing
is subject to the satisfaction (or waiver by the Parent in writing; provided
that any such waiver shall require the prior written consent of the Parent
Investor) of the following conditions as of the Closing Date: 

          (a)     
Each of the representations and warranties set forth in Section 8 will be true
and correct in all material respects at and as of the time of the Closing as
though then made, except for changes expressly required by this Agreement and
except for any representation or warranty that expressly relates to a specific
prior date. 

          (b)     
The Buyer will have performed and complied in all material respects with all of
the covenants and agreements required to be performed by the Buyer under this
Agreement at or prior to the Closing. 

          (c)      There
shall be no proceeding commenced or threatened against the Buyer or Sellers
involving this Agreement or the transactions contemplated herein or any
judgment, decree, injunction or order which prohibits the consummation of the
transactions contemplated by this Agreement. 

          (d)     
The pro forma consolidated financial statements of the Buyer (including the
Acquired Assets) shall have been completed in accordance with the Exchange Act
(as defined below), and the rules and regulations promulgated thereunder, and
the report of independent auditors with respect to such financial statements
completed and submitted. 

          (f)      The
Buyer shall have delivered to the Sellers the items set forth in Section 6.03.

          6.06.     
Pre-Closing Covenants.

          (a)     
Operations and Maintenance of the Business. From and after the date
hereof and prior to the Closing, unless the Buyer and the Parent Investor
otherwise consent in writing or except as set forth expressly herein, each
Selling Subsidiary will conduct their respective business only in the ordinary
course of business as conducted by such Selling Subsidiary consistent with past
practice.

          Furthermore,
except as may otherwise be required under this Agreement, no Selling Subsidiary
shall do any of the following, without the prior written consent of the Buyer
and the Parent Investor: 

                    (i)      enter
into any Contract, agreement or transaction, or incur or permit to be incurred,
any obligation or other Liabilities with respect to or materially affecting its
business, the Acquired Assets, and Parent shall not enter into any Contract,
agreement or transaction, or incur or permit to be incurred, any obligation or
other Liabilities with respect to the Parent Shares;

                    (ii)      remove
any of its assets (other than cash and cash equivalents) used in its business by
way of dividend, distribution, withdrawal or any other means;

                    (iii)      permit
to be incurred any Lien on any of its assets used in its business; 

                    (iv)     
increase the compensation payable or to become payable to any of its employees
retained in connection with its business, or otherwise enter into or alter any
employment or consulting agreement; 

                    (v)     
commence, enter into, or alter any profit sharing, deferred compensation, bonus,
option or purchase plan for its interests or other equity securities, pension,
retirement or incentive plan or any fringe benefit plan for its employees
retained in connection with its business; 

                    (vi)     
terminate the employment of any of its employees retained in connection with its
business or hire or engage any employees or consultants in connection with its
business, except in the ordinary course of its business; 

                    (vii)      cancel
or waive any Claims or rights of any Selling Subsidiary, with respect to or
materially affecting its business or the Acquired Assets, outside the ordinary
course of such Selling Subsidiary’s business and consistent with past practice;

                    (viii)     
change any accounting methods used by any Selling Subsidiary in connection with
its business, except and solely to the extent required by applicable generally
accepted accounting principles or Law; 

                    (ix)      pay
or incur any obligation or Liability, absolute or contingent, with respect to or
materially affecting its business or the Acquired Assets other than obligations
or Liabilities incurred in the ordinary course of its business and consistent
with past practice or purchase any asset other than in the ordinary course of
its business; 

                    (x)     
make any Tax election or settle or compromise any Tax Liability which could
reasonably be expected to have an adverse impact on the Taxes payable by Buyer;

                    (xi)     
enter into any joint venture, partnership or other similar arrangement or form
any other material arrangement for the operation of its business; and 

                    (xii)     
enter into any binding commitment to do any of the foregoing. 

          Notwithstanding
anything herein to the contrary the parties and Parent Investor agree that
Parent shall make a payment to Michael Matvieshen on or about the date hereof to
retire a portion of a debt outstanding from Parent to Mr. Matvieshen.

          (b)     
Consents. Sellers shall use their respective best efforts to obtain all
consents and approvals of Third Parties necessary or required for the Buyer to
acquire ownership of the Acquired Assets free and clear of all Liabilities,
obligations, Liens, Claims (including Third Party Claims, whether private,
governmental or otherwise) and encumbrances, excepting only Assumed Liabilities.

          (c)     
Information. From time to time at the Buyer’s request, upon reasonable
prior notice and at reasonable times during normal business hours, subject to
requirements of Law, the Sellers will provide to representatives of the Buyer
and its agents, employees and accounting, tax, legal and other advisors
(collectively, including the Buyer, the “Investigating Parties”) access
to each Seller’s premises, properties, operations and books and records, and
will cause each of the Sellers respective officers, employees, representatives,
agents and accounting, tax, legal and other advisors to furnish to Buyer and the
Investigating Parties such financial and operating data and other such
information with respect to the Business and the properties of such Seller as
the Investigating Parties shall request. 

          (d)     
Efforts to Close. Each party will use commercially reasonable efforts to
cause the conditions to Buyer’s and Sellers’ respective obligations to
consummate the transactions contemplated by this Agreement to be satisfied
including the preparation, execution and delivery of all agreements and
instruments contemplated hereunder to be executed and delivered by such party in
connection with or prior to the Closing. 

          (e)     
Schedules. The Sellers shall promptly (and in any event prior to the
Closing) advise Buyer, orally and in writing, of any change or event having, or
which would have (insofar as can be reasonably foreseen), a Material Adverse
Effect or would constitute, or with the passage of time would constitute, a
breach of any representation or warranty of the Sellers contained in this
Agreement. Sellers agree that, with respect to their representations and
warranties made in this Agreement, each of them will have a continuing
obligation to supplement or amend the schedules hereto with respect to any
matter hereafter arising or discovered which, if existing or known at the date
of this Agreement, would have been required to be set forth or described in the
schedules hereto; provided, however, that neither the supplementing or amending
of any schedules by Sellers, nor the discovery of any matters by Buyer in the
course of its investigations, shall be deemed to cure any breach of any
representation or warranty made in this Agreement or to have been disclosed as
of the date of this Agreement. 

          (f)     
Competitive Offers. Sellers shall not, directly or indirectly, and will
cause each of their respective officers, employees and Affiliates not to,
solicit or initiate the submission of proposals from, or solicit, encourage,
entertain or enter into arrangements, agreements or understandings with, or
discuss with or furnish information to, any Person (other than the Buyer and the
Investigating Parties) with respect to the acquisition in whatever form of all
or any portion of the Acquired Assets, the Business or the Parent Shares. 

          6.07.      Effect
of Failure to Close. If the Closing of the transactions contemplated herein
does not occur for any reason, then the rights and obligations of the Parties
hereunder shall terminate without any Liability of any party to any other
party.

SECTION 7 
REPRESENTATIONS, WARRANTIES AND COVENANTS OF
SELLERS 

          Sellers
hereby represent and warrant to the Buyer as follows: 

          7.01.      Each
Seller Subsidiary is a corporation duly organized, validly existing and in good
standing under the laws of the state of its incorporation. Parent is a
corporation duly organized, validly existing and in good standing under the laws
of the province of British Columbia, Canada. Each Seller has the power and the
authority and all Licenses and permits required by Governmental or Regulatory
Authorities to own and operate its assets and carry on the Business as now being
conducted. Except as set forth on Schedule 7.01, Parent does not have any
subsidiaries other then Seller Subsidiaries and no Seller Subsidiary owns,
beneficially or of record, any equity interest in any corporation, company,
partnership or other business organization or entity.

          7.02.      Sellers
have the requisite power and authority to execute and perform this Agreement and
all other agreements, documents and instruments to be entered into by each of
them, as applicable, in connection with the transactions contemplated hereby.

          7.03.     
With the exception of Great Lakes, which Epod Industries is the sole
stockholder, Parent is the sole stockholder of each Seller Subsidiary and Epod
Industries. The execution, delivery and performance of this Agreement and all
other agreements to be entered into in connection with the transactions
contemplated hereby have been duly authorized by the board of directors of each
Seller Subsidiary, and by Parent and Epod Industries as the sole stockholder of
each Seller Subsidiary, and do not violate or conflict with any provisions of
the organizational documents of any Seller Subsidiary or any agreement,
instrument, Law, order or regulation to which any Seller Subsidiary is a party
or by which a Seller Subsidiary is bound. All corporate action required to be
taken by Parent to authorize the execution, delivery and performance of this
Agreement and all other agreements to be entered into by Parent in connection
with the transactions contemplated hereby has been taken, and such execution,
delivery and performance do not violate or conflict with any provisions of the
organizational documents of Parent or any agreement, instrument, Law, order or
regulation to which Parent is a party or by which Parent is bound. No consent,
approval or authorization of, or filing with or notification to, any lender
(other then certain creditors with respect to the Assumed Liabilities), security
holder, Governmental or Regulatory Authority or other person or entity is
required by a Seller or in connection with the execution, delivery and
performance by such Seller of this Agreement and the consummation of the
transactions contemplated hereby. 

          7.04.     
Each Seller has all requisite corporate power and authority to execute and
deliver this Agreement and all other agreements to be entered into in connection
with the transactions contemplated hereby to which it is a party, and to perform
its obligations hereunder and thereunder. This Agreement has been, and upon
execution and delivery thereof, each of the other agreements to be entered into
in connection with the transactions contemplated hereby to which a Seller is a
party will be, duly and validly executed and delivered by such Seller and the
valid and binding obligations of each Seller, enforceable against such Seller in
accordance with their terms, except as enforceability may be limited by
bankruptcy, insolvency, reorganization, moratorium and other similar laws from
time to time in effect affecting the enforcement of creditors’ rights generally, and except as
enforcement of remedies may be limited by general equitable principles. 

          7.05.      Sellers
are the owner of and have good, valid and marketable title to the Acquired
Assets, which are indicated as being owned and transferred herein by each Seller
on schedules hereto, free and clear of all Liabilities, obligations, Liens,
Claims (including Third Party Claims, whether private, governmental or
otherwise) and encumbrances, excepting only Assumed Liabilities.

          7.06.      No
Seller has any Knowledge of any action, suit, litigation or proceeding pending
or threatened against it or otherwise or relating to the Acquired Assets or the
Business, nor does such Seller know of any basis for any such action, or of any
governmental investigation relating to the Acquired Assets or the Business. 

          7.07.      No
Seller has Knowledge of any order, writ, injunction or decree that has been
issued by, or requested of, any court or Governmental or Regulatory Authority
which is against, or binding on such Seller which may affect, limit or control
the Acquired Assets or Buyer’s use thereof. 

          7.08.      Each
Seller has obtained all required approvals or authorizations of this Agreement
and any other agreements to be entered into in connection with the transactions
contemplated hereby which are required by applicable Laws or otherwise in order
to make this Agreement or any other agreements entered into in connection with
the transactions contemplated hereby binding upon Seller. 

          7.09.     
There are no Liens for any federal, state, county or local franchise, income,
excise, property, business, sales, commercial rent, employment or other Taxes
upon the Acquired Assets. Each Seller has timely filed all federal, foreign,
state, county and local franchise, income, excise, property, business, sales,
commercial rent and employment and other Tax Returns which are required to be
filed through the Closing Date, and has paid, or will pay, all Taxes which are
due and payable on or before the Closing Date.

          7.10.      Each
Seller has, in all material respects, complied and is in compliance with all
applicable Laws, orders and regulations of any Governmental or Regulatory
Authority applicable to such Seller, its operation of the Business, assets or
property or its operations including, without limitation, applicable Laws
relating to zoning, building codes, antitrust, occupational safety and health,
Environmental Law, consumer product safety, product liability, hiring, wages,
hours, employee benefit plans and programs, collective bargaining and
withholding and social security taxes.

          7.11.      Sellers
do not know of any facts or circumstances not disclosed to Buyer which indicate
that the Acquired Assets may be adversely affected or which otherwise should be
disclosed to Buyer in order to make any of the representations or warranties
made herein on the part of any Seller not misleading. No representation or
warranty by any Seller contained in this Agreement, and no statement contained
in any schedule, exhibit, certificate or other instrument furnished to Buyer
under or in connection with this Agreement, contains any untrue statement of any
material fact, or omits to state any material fact necessary in order to make
the statements contained herein or therein not misleading. 

          7.12.      The
representations and warranties of each Seller contained in this Agreement will
be true and correct on and as of the Closing Date with the same force and effect
as though such representations and warranties had been made on and as of the
Closing Date. 

          7.13.      With
respect to the Common Stock being issued to Parent or otherwise underlying any
of the Assumed Liabilities, said shares are being acquired for investment
purposes only and not with a view towards resale or distribution. Sellers have
had an opportunity to ask questions of Buyer and have done so. The shares of
Common Stock are restricted securities that have not been registered for re-sale
pursuant to the Securities Act. Sellers understand that the Common Stock may not
be sold, transferred, assigned or hypothecated or otherwise distributed to its
stockholders as a dividend or otherwise, absent the effectiveness of a
registration statement covering the sale of such Common Stock or an exemption
from the registration requirements the Securities Act.

          7.14.      No
Seller has any Liability or obligation to pay any fees or commissions to any
broker, finder or agent with respect to the transactions contemplated by this
Agreement or any other agreements to be entered into in connection with the
transactions contemplated hereby. 

          7.15.      The
Parent and Epod Industries, as the case may be, are the sole record and
beneficial holder of the Parent Shares, and the Parent Shares constitute all of
the issued and outstanding shares of capital stock of each of Great Lakes and
Epod Europe held by Epod Industries and Parent respectively, and each has no
other rights to purchase, acquire or receive any shares of Great Lakes’ or Epod
Europe’s capital stock. The Parent Shares represent all of the issued and
outstanding shares of capital stock of each of Great Lakes and Epod Europe.
There is no restriction affecting the ability of the Parent to transfer the
title and ownership of the Parent Shares to Buyer, and upon delivery of the
certificates for the Parent Shares to Buyer pursuant to the terms of this
Agreement and payment of the Purchase Price at the Closing, Buyer will acquire
record and legal title to such Parent Shares, free and clear of all Liabilities,
obligations, Liens, Claims (including Third Party Claims) and encumbrances. 

SECTION 8 
REPRESENTATIONS AND WARRANTIES OF BUYER

          Except
as disclosed by Buyer on Buyer’s reports, statements, schedules, prospectuses,
and other documents filed with the Securities and Exchange Commission (the
“SEC”) in accordance with the Securities and Exchange Act of 1934, as
amended, and the rules and regulations promulgated thereunder (the “Exchange
Act”) (collectively, as amended and/or supplemented to date, the
“Securities Filings”), Buyer represents and warrants to the Sellers as
follows: 

          8.01.      Buyer
is a corporation duly organized, validly existing and in good standing under the
laws of the State of Nevada. 

          8.02.      Buyer
is duly qualified to conduct business under the laws each jurisdiction where
such qualification is necessary, except where the failure to be so qualified
would not have a Material Adverse Effect.

          8.03.     
Buyer has all requisite corporate power and authority to execute and deliver
this Agreement and all other agreements to be entered into in connection with
the transactions contemplated hereby to which it is a party, and to perform its
obligations hereunder and thereunder. The execution and delivery by Buyer of
this Agreement and all other agreements to be entered into in connection with
the transactions contemplated hereby to which it is a party, and the performance
by Buyer of its obligations hereunder and thereunder, have been duly and validly
authorized by all necessary corporate action on the part of Buyer, including any vote of
stockholders. This Agreement has been, and upon execution and delivery thereof,
each of the other agreements to be entered into in connection with the
transactions contemplated hereby to which Buyer is a party will be, duly and
validly executed and delivered by Buyer and the valid and binding obligations of
Buyer, enforceable against Buyer in accordance with their terms, except as
enforceability may be limited by bankruptcy, insolvency, reorganization,
moratorium and other similar laws from time to time in effect affecting the
enforcement of creditors’ rights generally, and except as enforcement of
remedies may be limited by general equitable principles.

          8.04.      There
is no requirement applicable to Buyer to make any filing with, or to obtain any
permit, authorization, consent or approval of, any governmental entity as a
condition to the lawful consummation by Buyer of the transactions contemplated
pursuant to this Agreement. The execution, delivery and performance of this
Agreement by Buyer does not, and the consummation of the transactions
contemplated hereby will not (with or without the giving of notice, the lapse of
time or both), (i) conflict with or result in any breach of any provision of the
Articles of Incorporation or Bylaws of Buyer, or (ii) violate any applicable
Law, rule, regulation, order, writ, judgment, ordinance, injunction or decree of
any governmental entity to which Buyer is a party or is bound.

          8.05     
The authorized capital of Buyer consists, immediately prior to the Closing, of
75,000,000 shares of Common Stock, 2,849,000 shares of which are issued and
outstanding immediately prior to the Closing. All of the outstanding shares of
common stock have been duly authorized, are fully paid and nonassessable and
were issued in compliance with all applicable federal and state securities laws.
Buyer holds no treasury stock and no shares of common stock in its treasury. The
rights, privileges and preferences of the common stock are as stated in Buyer’s
Articles of Incorporation and as provided by the general corporation law of the
jurisdiction of the Buyer’s incorporation.

           
8.06.      The shares of Common Stock to be issued to
Parent in accordance with Section 4.01 are, and will at the time of issuance be,
duly authorized, validly issued and fully paid and non-assessable in all
respects, free from any pre-emptive or other rights, and the issuance thereof
will not violate any agreement or trigger the anti dilution, right of first
refusal, co-sale or similar provisions of any agreement to which the Buyer is
bound. Buyer has reserved a sufficient number of shares of Common Stock for
issuance upon conversion or exercise of the Assumed Liabilities. Upon issuance
in accordance with the terms of the relevant Assumed Liability to which such
shares of Common Stock relate, such shares will be duly authorized, validly
issued, fully paid and non-assessable in all respects, free from any pre-emptive
or other rights (other than as entered into after the date of Closing), and the
issuance thereof will not violate any agreement or trigger the anti-dilution,
right of first refusal, co-sale or similar provisions of any agreement to which
Buyer is bound. 

           
8.07.      All Securities Filings required to be
filed by Buyer with the SEC pursuant to the Exchange Act, along with all
exhibits to such annual, quarterly and other reports as available on the SEC’s
EDGAR database website, are true, correct and complete in all material respects
as of the date of filing thereof, and said reports do not, as of the date of
filing thereof, fail disclose or omit any material fact, agreement or matter
relating to the Buyer. 

           
8.08      There is no claim, action, suit,
proceeding, arbitration, complaint, charge or investigation pending or to
Buyer’s Knowledge, currently threatened against Buyer or, to the best of Buyer’s
Knowledge, threatened against any officer or director of Buyer, that questions
the validity of this Agreement or the right of Buyer to enter into it, or to
consummate the transactions contemplated hereby, or could have or reasonably be expected to have, either
individually or in the aggregate, a material adverse effect upon the Business.
Neither Buyer nor, to the best of Buyer’s Knowledge, any of its officers or
directors, is a party or is named as subject to the provisions of any order,
writ, injunction, judgment or decree of any court or government agency or
instrumentality (in the case of officers or directors, such as would affect
Buyer). There is no action, suit, proceeding or investigation by Buyer pending
or which Buyer intends to initiate. The foregoing includes, without limitation,
actions, suits, proceedings or investigations pending or threatened in writing
(or any basis therefore known to Buyer) involving the prior employment of any of
Buyer’s employees, their services provided in connection with the Business, or
any information or techniques allegedly proprietary to any of their former
employers, or their obligations under any agreements with prior employers. 

           
8.09.      Except as expressly set forth in this
Section 8, Buyer makes no other representation or warranty with respect to the
transactions contemplated by this Agreement or other agreements to be entered
into in connection with the transactions contemplated hereby. 

SECTION 9 
SURVIVAL OF REPRESENTATIONS AND WARRANTIES;
INDEMNIFICATION 

           
9.01      Survival of Representations and
Warranties. All of Buyer’s representations and warranties in this Agreement
or in any other agreements to be entered into in connection with the
transactions contemplated hereby to which it is a party, and all of Sellers’
representations and warranties in this Agreement, in any other agreements to be
entered into in connection with the transactions contemplated hereby, or in any
instrument delivered pursuant hereto or thereto, shall survive the Closing Date
and continue until the date which is eighteen (18) months after the Closing
Date; provided, however, that (i) any claim based on fraud shall survive
indefinitely, (ii) any claim for violation of the representations and warranties
with respect to Taxes, employee matters or Environmental Law shall survive until
the expiration of the applicable statute of limitations applicable to any claim
or right of action related thereto, (iii) the covenants and agreements contained
in this Agreement and the other agreements to be entered into in connection with
the transactions contemplated hereby and to be performed at the Closing Date
will survive until fully performed in accordance with their terms, and (iv) any
claim for indemnity asserted pursuant to Section 9.02 shall, if made within the
applicable time period set forth above with respect to an accrued Liability,
survive indefinitely. However, no claim for indemnity may be asserted under
Section 9.02 unless notice of such claim is given to Parent or Buyer, as the
case may be, prior to the appropriate period(s) specified in the preceding
sentence. 

           
9.02      Indemnification. 

           
(a)      Parent agrees, from and after the Closing
Date, for the appropriate period(s) specified in Section 9.01, above, to
indemnify and hold Buyer and its officers, directors, agents or Affiliates and
their respective successors and assigns (the “Buyer Indemnified
Parties”), harmless from and against any Loss incurred by any Buyer
Indemnified Party, directly or indirectly, resulting from (i) noncompliance with
any applicable bulk sales or transfer Law, (ii) any Liability or Contract of, or
Claim against, a Seller, whether contingent or absolute, direct or indirect,
known or unknown, matured or unmatured (including but not limited to Liabilities
for Taxes), (iii) any Liability or Claim arising in any way from any service
rendered, or action taken by, or relating to the operations of, a Seller prior
to the Closing Date, (iv) any Liability or Claim under any Environmental Laws
relating to any event, action or failure to act which occurred prior to the
Closing Date, or (v) the breach or inaccuracy of or failure to comply with, or
the existence of any facts resulting in the inaccuracy of, any of the
warranties, representations, conditions, covenants or agreements of a Seller
contained in this Agreement or in any agreement or document delivered pursuant hereto or in connection herewith,
or arising out of the consummation of the transactions contemplated hereby. 

           
(b)      Buyer agrees from and after the Closing
Date, for the appropriate period(s) specified in Section 9.01, above, to
indemnify and hold Sellers and their respective Affiliates, successors and
assigns (the “Seller Indemnified Parties”) harmless from and against any
Loss incurred by any Seller Indemnified Party directly or indirectly resulting
from (i) any Liability or Claim arising in any way from any service rendered, or
action taken by, or relating to the operations of, Buyer after the Closing Date,
(ii) any Liability or Claim under any Environmental Laws relating to any event,
action or failure to act which occurs after the Closing Date, or (iii) any Claim
arising out of Buyer’s breach, failure to fully repay and satisfy, default in or
failure to comply with the terms of, the Assumed Liabilities or any breach of
any warranties, representations, conditions, covenants or agreements of Buyer
contained in this Agreement to which the Buyer is a party, or in any other
agreement, certificate or document delivered pursuant to or in connection with
this Agreement or arising out of the Closing of the transactions contemplated
hereby. 

           
(c)      If any Third Party shall notify any party
(the “Indemnified Party”) with respect to any matter which may give rise
to a claim for indemnification against any other party (the “Indemnifying
Party”) under this Section 9, then the Indemnified Party shall notify
each Indemnifying Party thereof promptly; provided, however, that no delay on
the part of the Indemnified Party in notifying any Indemnifying Party shall
relieve the Indemnifying Party from any Liability or obligation hereunder unless
(and then solely to the extent) the Indemnifying Party thereby is materially
damaged. In the event any Indemnifying Party notifies the Indemnified Party
within thirty (30) days after the Indemnified Party has given notice of the
matter that the Indemnifying Party is assuming the defense thereof, (i) the
Indemnifying Party will defend the Indemnified Party against the matter with
counsel of its choice reasonably satisfactory to the Indemnified Party, (ii) the
Indemnified Party may retain separate co-counsel (at its cost), (iii) the
Indemnified Party will not consent to the entry of any judgment or enter into
any settlement with respect to the matter without the written consent of the
Indemnifying Party (not to be withheld unreasonably), and (iv) the Indemnifying
Party will not consent to the entry of any judgment with respect to the matter,
or enter into any settlement which does not include a provision whereby the
plaintiff or claimant in the matter releases the Indemnified Party from all
Liability with respect thereto, without the written consent of the Indemnified
Party (not to be withheld unreasonably). In the event the Indemnifying Party
fails to assume the defense of the matter as provided herein within thirty (30)
days after the Indemnified Party has given notice thereof, the Indemnified Party
may defend against, or enter into any settlement with respect to, the matter in
any manner it reasonably may deem appropriate. 

           
(d)      After the Closing Date, the right of
indemnification under this Section 9 shall be the sole and exclusive remedy
available to any party for any claim or cause of action arising under this
Agreement or other agreements to be entered into in connection with the
transactions contemplated hereby in connection with any breach of any
representation, warranty, covenant or provision of this Agreement this
Agreement, other agreements to be entered into in connection with the
transactions contemplated hereby or otherwise; provided, however, that this
exclusive remedy does not preclude a party from bringing an action for specific
performance or other equitable remedy to require a party to perform its
obligations under this Agreement. Each party expressly waives any rights it may
have to make a claim against the other pursuant to any constitutional,
statutory, or common law authorities. The provisions of this Section 9.02(d)
shall not apply to claims arising out of or relating to the fraud, gross
negligence or willful misconduct of the parties. 

SECTION 10 
PRESERVATION OF BOOKS AND RECORDS 

           
For a period of three (3) years after the Closing date, Buyer shall preserve the
books and records of Sellers delivered to Buyer; and Sellers shall similarly
make available to Buyer any records which Buyer permits Sellers to retain; each
party will make such books and records available to the other party at all
reasonable times and permit the other party to make extracts from or copies of
all such records. 

SECTION 11 
CERTAIN OTHER COVENANTS AND AGREEMENTS

           
11.01.    Further Assurances. Upon the request of either
party hereto, the other party will execute and deliver to the requesting party,
or such party’s nominee, all such instruments and documents of further assurance
or otherwise, and will do any and all such acts and things as may reasonably be
required to carry out the obligations of such party hereunder and to more
effectively consummate the transactions contemplated hereby, including, without
limitation, submitting information required by a Governmental or Regulatory
Authority, obtaining all consents and approvals from Third Parties, under
leases, agreements and other Contracts. 

           
11.02.    Quotation. Buyer shall use its best efforts to
maintain the eligibility for quotation of the Common Stock on the over the
counter bulletin board. 

           
11.03.    SEC Reports. Buyer shall file with the SEC all
reports that are required to be filed pursuant to the Exchange Act with respect
to this Agreement and the transactions contemplated hereby. 

SECTION 12 
MISCELLANEOUS 

           
12.01.    Governing Law. This Agreement shall be construed
and interpreted in accordance with the laws of the State of Delaware and shall
be enforceable exclusively in the courts thereof.

           
12.02.    Modification. This Agreement may be modified,
amended or terminated, and the requirements of any provision hereof may be
waived, with the mutual consent of Seller and Buyer by written instrument signed
by them or their respective successors or assigns in any manner deemed necessary
or appropriate by them. 

           
12.03.    Counterparts. This Agreement may be executed in
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument. 

           
12.04.    Notices. Any notice or other communication
hereunder may be sent by any means (including facsimile or email or other
electronic means, provided that receipt thereof is acknowledged and confirmed by
the recipient) and shall be effective upon receipt; except that, if sent via
domestic certified mail or via international overnight courier such as Federal
Express, said notice shall be conclusively deemed to have been received by a
party hereto and be effective on the earlier of (a) the actual date of receipt,
or, if earlier, (b) the third business day following the date given to the post
office or courier for delivery. In addition to such notices and communications
as shall be addressed to such party at the address set forth at the outset of
this Agreement (or such other address as such party shall specify to the other
party in writing), mandatory copies, sent in such manner, shall be delivered to
the additional addressees set forth below: 

	As to Seller: 	EPOD Solar Inc 
	  	5 – 215 Neave Road 
	  	Kelowna British Columbia, Canada V1V 2L9 
	  	Attn: Michael Matvieshen, President 
	  	  
	As to Buyer: 	Allora Minerals Inc. 
	  	5 – 215 Neave Road 
	  	Kelowna British Columbia, Canada V1V 2L9 
	  	Attn: Michael Matvieshen, President
  

           
A copy shall also be given to Ellenoff Grossman & Schole LLP, 150 East 42nd
Street, 11th Floor, New York, New York 10017, Attention: Stuart Neuhauser, Esq.

           
12.05.    Entire Agreement. This Agreement, together with
its schedules, exhibits and the other agreements to be entered into in
connection with the transactions contemplated hereby, constitutes the entire
understanding among the parties and supersedes all other understandings and
agreements, oral or written, with respect to the subject matter hereof. 

           
12.06.    Headings. The descriptive headings of the
several sections and paragraphs of this Agreement are inserted for convenience
only and do not constitute a part of this Agreement. 

           
12.07.    Equitable Remedies. In the event that any party
to this Agreement shall default in the performance of any obligation, covenant
or agreement hereunder, the other parties to this Agreement shall, in addition
to all other remedies which may be available to it, be entitled to injunctive
and equitable relief, including without limitation specific performance, and
shall be entitled to recover from the defaulting party or parties its costs and
expenses (including reasonable attorneys’ fees) incurred by it in securing such
injunctive or equitable relief. 

           
12.08.    Severability. In the event that any provision of
this Agreement shall be held to be invalid or unenforceable by a court of
competent jurisdiction, the remainder of this Agreement should remain in full
force and effect and be interpreted as if such invalid or unenforceable
provision had not been a part hereof; provided, however, if any particular
portion of this Agreement shall be adjudicated invalid or unenforceable by
reason of the length of time or scope of applicability provided for herein, this
Agreement shall be deemed amended to diminish such time and/or reduce such scope
to the longest enforceable time and the broadest enforceable scope of
applicability. 

           
12.09.    Assignment. Buyer shall be entitled to assign
all or part of its rights, title and interest under this Agreement to an
Affiliate; provided that such subsidiary or Affiliate shall assume the
corresponding obligations of Buyer under this Agreement. A copy of any
assignment made hereunder shall be promptly forwarded to Parent. Sellers may not
assign all or any part of their respective rights, title and interest under this
Agreement without the prior written consent of Buyer. 

           
12.10.   Successors and Assigns. This Agreement shall be
binding upon and inure to the benefit of the parties herein and their successors
and permitted assigns. 

           
12.11.   Publicity. Neither party shall not issue nor cause the
publication of any press release or other announcement with respect to this
Agreement or the transactions contemplated hereby without the consent of the
other party, which consent shall not be unreasonably withheld, except where such
release or announcement is required by applicable Law or the rules of any stock
exchange, stock market or Governmental or Regulatory Authority having authority
over any party.

           
12.12.   Tax Reporting. The parties hereto agree and
acknowledge that the determination of the price for each of the Acquired Assets
being sold by Sellers to Buyer, as set forth in this Agreement, is the result of
arm’s-length negotiations between the parties, and the parties agree and warrant
and represent to each other, that their respective tax returns and those of any
Affiliate entity shall report the transactions contemplated by this Agreement in
accordance with the characterization and allocated prices of the various assets
set determined pursuant to Section 4.02 herein, and that they will not
voluntarily take any position inconsistent therewith upon any examination of any
such tax return or in any litigation with respect thereto. 

           
12.13.   Third Party Beneficiary. The parties agree and
acknowledge that the Parent Investor is an intended third party beneficiary of
the representations and warranties of Sellers and Buyer contained in Sections 7
and 8 herein, respectively. 

           
IN WITNESS WHEREOF, the parties have executed this Agreement as of the date
first above written. 

	 	SELLERS: 
	 	 
	 	EPOD SOLAR INC. 
	 	 
	 	 
	 	By: 	/s/
      Michael Matvieshen 
	 	Name: 	Michael Matvieshen 
	 	Its: 	Chief Executive Officer 
	 	 	 
	 	EPOD SOLAR (WALES) LIMITED
  
	 	 
	 	 
	 	By: 	/s/
      Michael Matvieshen 
	 	Name: 	Michael Matvieshen 
	 	Its: 	  
	 	 	 
	 	EPOD INDUSTRIES, INC. 
	 	 
	 	 
	 	By: 	/s/
      Michael Matvieshen 
	 	Name: 	Michael Matvieshen 
	 	Its: 	  
	 	 	 
	 	BUYER: 
	 	 
	 	ALLORA MINERALS, INC.
    
	 	 
	 	 
	 	By: 	/s/
      Michael Matvieshen
	 	Name: Michael Matvieshen 
	 	Its: 	President and Chief Executive Officer
  

EXHIBIT A 

Bill of Sale 

EXHIBIT B 

Assignment of Intellectual Property 

EXHIBIT C 

Assignment and Assumption of Contracts Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00160-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00160-of-00352.parquet"}]]